PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cmrPermissionsJournals.ASM.orgJournalCMR ArticleJournal InfoAuthorsReviewers
 
Clin Microbiol Rev. 1997 January; 10(1): 86–124.
PMCID: PMC172945

Infections in solid-organ transplant recipients.

Abstract

Solid-organ transplantation is a therapeutic option for many human diseases. Infections are a major complication of solid-organ transplantation. All candidates should undergo a thorough infectious-disease screening prior to transplantation. There are three time frames, influenced by surgical factors, the level of immunosuppression, and environmental exposures, during which infections of specific types most frequently occur posttransplantation. Most infections during the first month are related to surgical complications. Opportunistic infections typically occur from the second to the sixth month. During the late posttransplant period (beyond 6 months), transplantation recipients suffer from the same infections seen in the general community. Opportunistic bacterial infections seen in transplant recipients include those caused by Legionella spp., Nocardia spp., Salmonella spp., and Listeria monocytogenes. Cytomegalovirus is the most common cause of viral infections. Herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and others are also significant pathogens. Fungal infections, caused by both yeasts and mycelial fungi, are associated with the highest mortality rates. Mycobacterial, pneumocystis, and parasitic diseases may also occur.

Full Text

The Full Text of this article is available as a PDF (564K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abbott MR, Smith DD. Mycobacterial infections in immunosuppressed patients. Med J Aust. 1981 Apr 4;1(7):351–353. [PubMed]
  • Abu-Farsakh H, Cagle PT, Buffone GJ, Bruner JM, Weilbaecher D, Greenberg SD. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder. Arch Pathol Lab Med. 1992 Jan;116(1):93–95. [PubMed]
  • Agarwal A, Gupta A, Sakhuja V, Talwar P, Joshi K, Chugh KS. Retinitis following disseminated cryptococcosis in a renal allograft recipient. Efficacy of oral fluconazole. Acta Ophthalmol (Copenh) 1991 Jun;69(3):402–405. [PubMed]
  • Ajello L, Georg LK, Steigbigel RT, Wang CJ. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia. 1974 May-Jun;66(3):490–498. [PubMed]
  • Albes J, Haverich A, Freihorst J, von der Hardt H, Manthey-Stiers F. Management of mycotic rupture of the ascending aorta after heart-lung transplantation. Ann Thorac Surg. 1990 Dec;50(6):982–983. [PubMed]
  • Aldape KD, Fox HS, Roberts JP, Ascher NL, Lake JR, Rowley HA. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol. 1991 Apr;95(4):499–502. [PubMed]
  • Alexander JA, Brouillette DE, Chien MC, Yoo YK, Tarter RE, Gavaler JS, Van Thiel DH. Infectious esophagitis following liver and renal transplantation. Dig Dis Sci. 1988 Sep;33(9):1121–1126. [PubMed]
  • Algan M, Jonon B, George JL, Lion C, Kessler M, Burdin JC. Listeria monocytogenes endophthalmitis in a renal-transplant patient receiving ciclosporin. Ophthalmologica. 1990;201(1):23–27. [PubMed]
  • Allen KA, Markin RS, Rennard SI, Shaw BW, Jr, Thompson AB, Wood RP, Woods GS, Linder J. Bronchoalveolar lavage in liver transplant patients. Acta Cytol. 1989 Jul-Aug;33(4):539–543. [PubMed]
  • Alsip SG, Cobbs CG. Pseudallescheria boydii infection of the central nervous system in a cardiac transplant recipient. South Med J. 1986 Mar;79(3):383–384. [PubMed]
  • al-Sulaiman MH, Dhar JM, al-Hasani MK, Haleem A, al-Khader A. Tuberculous interstitial nephritis after kidney transplantation. Transplantation. 1990 Jul;50(1):162–164. [PubMed]
  • Ampel NM, Wing EJ. Legionella infection in transplant patients. Semin Respir Infect. 1990 Mar;5(1):30–37. [PubMed]
  • Anandi V, John TJ, Walter A, Shastry JC, Lalitha MK, Padhye AA, Ajello L, Chandler FW. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient. J Clin Microbiol. 1989 Oct;27(10):2226–2229. [PMC free article] [PubMed]
  • Anderson DJ, Schmidt C, Goodman J, Pomeroy C. Cryptococcal disease presenting as cellulitis. Clin Infect Dis. 1992 Mar;14(3):666–672. [PubMed]
  • Andrews W, Fyock B, Gray S, Coln D, Hendrickse W, Siegel J, Belknap B, Hogge A, Benser M, Kennard B, et al. Pediatric liver transplantation: the Dallas experience. Transplant Proc. 1987 Aug;19(4):3267–3276. [PubMed]
  • Arduino RC, Johnson PC, Miranda AG. Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine. Clin Infect Dis. 1993 Apr;16(4):505–512. [PubMed]
  • Armes JE, Angus P, Southey MC, Battaglia SE, Ross BC, Jones RM, Venter DJ. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Cancer. 1994 Nov 1;74(9):2436–2441. [PubMed]
  • Arnold JC, Nouri-Aria KT, O'Grady JG, Portmann BC, Alexander GJ, Williams R. Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome. Clin Investig. 1993 Mar;71(3):191–196. [PubMed]
  • Arnold JC, Portmann BC, O'Grady JG, Naoumov NV, Alexander GJ, Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology. 1992 Aug;16(2):285–292. [PubMed]
  • Arnouts PJ, Ramael MR, Ysebaert DK, Verpooten GA, de Broe ME, van Marck EA, Pattyn SR. Legionella pneumophila peritonitis in a kidney transplant patient. Scand J Infect Dis. 1991;23(1):119–122. [PubMed]
  • Arnow PM, Andersen RL, Mainous PD, Smith EJ. Pumonary aspergillosis during hospital renovation. Am Rev Respir Dis. 1978 Jul;118(1):49–53. [PubMed]
  • Ascher NL, Simmons RL, Marker S, Klugman J, Najarian JS. Tuberculous joint disease in transplant patients. Am J Surg. 1978 Jun;135(6):853–856. [PubMed]
  • Ascher NL, Simmons RL, Marker S, Najarian JS. Listeria infection in transplant patients. Five cases and a review of the literature. Arch Surg. 1978 Jan;113(1):90–94. [PubMed]
  • Avery RK. Infections and immunizations in organ transplant recipients: a preventive approach. Cleve Clin J Med. 1994 Sep-Oct;61(5):386–392. [PubMed]
  • Azadian BS, Beck A, Curtis JR, Cherrington LE, Gower PE, Phillips M, Eastwood JB, Nicholls J. Disseminated infection with mycobacterium chelonei in a haemodialysis patient. Tubercle. 1981 Dec;62(4):281–284. [PubMed]
  • Bach MC, Adler JL, Breman J, P'eng FK, Sahyoun A, Schlesinger RM, Madras P, Monaco AP. Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet. 1973 Jan 27;1(7796):180–184. [PubMed]
  • Badger IL, Crosby HA, Kong KL, Baker JP, Hutchings P, Elliott TS, McMaster P, Bion JF, Buckels JA. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplant Proc. 1991 Feb;23(1 Pt 2):1460–1461. [PubMed]
  • Bailey TC, Ettinger NA, Storch GA, Trulock EP, Hanto DW, Dunagan WC, Jendrisak MD, McCullough CS, Kenzora JL, Powderly WG. Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants. Am J Med. 1993 Sep;95(3):273–278. [PubMed]
  • Balfour HH, Jr, Chace BA, Stapleton JT, Simmons RL, Fryd DS. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med. 1989 May 25;320(21):1381–1387. [PubMed]
  • Balfour HH, Jr, Sachs GW, Welo P, Gehrz RC, Simmons RL, Najarian JS. Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial. Birth Defects Orig Artic Ser. 1984;20(1):289–304. [PubMed]
  • Weinberg JM. Issues in the pathophysiology of nephrotoxic renal tubular cell injury pertinent to understanding cyclosporine nephrotoxicity. Transplant Proc. 1985 Aug;17(4 Suppl 1):81–90. [PubMed]
  • Balk AH, Weimar W, Rothbarth PH, Meeter K, Metselaar HJ, Mochtar B, Simoons ML. Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience. Infection. 1993 Jul-Aug;21(4):195–200. [PubMed]
  • Ballardie FW, Winearls CG, Williams G. Cyclosporin and steroids in renal transplantation: risk of Pneumocystis carinii pneumonia? Lancet. 1984 Sep 15;2(8403):638–639. [PubMed]
  • Barbara JA, Clarkson AR, LaBrooy J, McNeil JD, Woodroffe AJ. Candida albicans arthritis in a renal allograft recipient with an interaction between cyclosporin and fluconazole. Nephrol Dial Transplant. 1993;8(3):263–266. [PubMed]
  • Baringer JR, Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973 Mar 29;288(13):648–650. [PubMed]
  • Barkholt L, Ericzon BG, Tollemar J, Malmborg AS, Ehrnst A, Wilczek H, Andersson J. Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int. 1993 Mar;6(2):77–84. [PubMed]
  • Barkholt LM, Ericzon BG, Ehrnst A, Forsgren M, Andersson JP. Cytomegalovirus infections in liver transplant patients: incidence and outcome. Transplant Proc. 1990 Feb;22(1):235–237. [PubMed]
  • Barton IK, Nicholson F. Use of pooled immunoglobulin and acyclovir as prophylaxis against cytomegalovirus disease in recipients of renal allografts. Nephrol Dial Transplant. 1991;6(7):525–526. [PubMed]
  • Basadonna G, Feria A, Perez R, Klein H, Sturges M, Colquhoun S. Incidence of infection and acute rejection after cytomegalovirus immune globulin prophylaxis in renal transplantation. Transplant Proc. 1994 Oct;26(5 Suppl 1):52–53. [PubMed]
  • Basgoz N, Preiksaitis JK. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am. 1995 Dec;9(4):901–923. [PubMed]
  • Bauling PC, Weil R, 3rd, Schröter GP. Legionella lung abscess after renal transplantation. J Infect. 1985 Jul;11(1):51–55. [PubMed]
  • Bell R, Sheil AG, McDonald JA, McCaughan GW. The role of CMV immune prophylaxis in patients at risk of primary CMV infection following orthotopic liver transplantation. Transplant Proc. 1989 Oct;21(5):3781–3782. [PubMed]
  • Bell TJ, Williams GB. Successful treatment of tuberculosis in renal transplant recipients. J R Soc Med. 1978 Apr;71(4):265–268. [PMC free article] [PubMed]
  • Benedict LM, Kusne S, Torre-Cisneros J, Hunt SJ. Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review. Clin Infect Dis. 1992 Jul;15(1):17–21. [PubMed]
  • Ben Hamida F, Achard JM, Westeel PF, Chandenier J, Bouzernidj M, Petit J, Carme B, Fournier A. Leg granuloma due to Neocosmospora vasinfecta in a renal graft recipient. Transplant Proc. 1993 Jun;25(3):2292–2292. [PubMed]
  • Ben Hamida M, Bedrossian J, Pruna A, Fouqueray B, Metivier F, Idatte JM. Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient. Transplant Proc. 1993 Jun;25(3):2290–2291. [PubMed]
  • Bensousan T, Garo B, Islam S, Bourbigot B, Cledes J, Garre M. Possible transfer of Pneumocystis carinii between kidney transplant recipients. Lancet. 1990 Oct 27;336(8722):1066–1067. [PubMed]
  • Berenguer J, Prieto M, Mir J, Cordoba J, Rayón M. Hepatitis C viral infection after orthotopic liver transplantation. Adv Exp Med Biol. 1994;368:173–179. [PubMed]
  • Berk MR, Meyers AM, Cassal W, Botha JR, Myburgh JA. Non-typhoid salmonella infections after renal transplantation. A serious clinical problem. Nephron. 1984;37(3):186–189. [PubMed]
  • Bibashi E, Papagianni A, Kelesidis A, Antoniadou R, Papadimitriou M. Peritonitis due to Aspergillus niger in a patient on continuous ambulatory peritoneal dialysis shortly after kidney graft rejection. Nephrol Dial Transplant. 1993;8(2):185–187. [PubMed]
  • Bisbe J, Vilardell J, Valls M, Moreno A, Brancos M, Andreu J. Transient fungemia and Candida arthritis due to Candida zeylanoides. Eur J Clin Microbiol. 1987 Dec;6(6):668–669. [PubMed]
  • Bjøro K, Frøland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med. 1994 Dec 15;331(24):1607–1611. [PubMed]
  • Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope. 1980 Apr;90(4):635–648. [PubMed]
  • Blohmé I, Nyberg G, Jeansson S, Svalander C. Adenovirus infection in a renal transplant patient. Transplant Proc. 1992 Feb;24(1):295–295. [PubMed]
  • Bocchi EA, Bellotti G, Uip D, Kalil J, de Lourdes Higuchi M, Fiorelli A, Stolf N, Jatene A, Pilleggi F. Long-term follow-up after heart transplantation in Chagas' disease. Transplant Proc. 1993 Feb;25(1 Pt 2):1329–1330. [PubMed]
  • Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):413–437. [PubMed]
  • Bogers AJ, van't Wout JW, Cats VM, Quaegebeur JM, Huysmans HA. Mediastinal rupture of a thoracoabdominal mycotic aneurysm caused by Salmonella typhimurium in an immunocompromised patient. Eur J Cardiothorac Surg. 1987;1(2):116–118. [PubMed]
  • Boivin G, Erice A, Crane DD, Dunn DL, Balfour HH., Jr Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis. Antimicrob Agents Chemother. 1993 Feb;37(2):357–359. [PMC free article] [PubMed]
  • Bolivar R, Satterwhite TK, Floyd M. Cutaneous lesions due to Mycobacterium kansasii. Arch Dermatol. 1980 Feb;116(2):207–208. [PubMed]
  • Boon AP, Adams DH, Buckels J, McMaster P. Cerebral aspergillosis in liver transplantation. J Clin Pathol. 1990 Feb;43(2):114–118. [PMC free article] [PubMed]
  • Boon AP, O'Brien D, Adams DH. 10 year review of invasive aspergillosis detected at necropsy. J Clin Pathol. 1991 Jun;44(6):452–454. [PMC free article] [PubMed]
  • Bortolussi RA, MacDonald MR, Bannatyne RM, Arbus GS. Treatment of Candida peritonitis by peritoneal lavage with amphotericin B. J Pediatr. 1975 Dec;87(6 Pt 1):987–988. [PubMed]
  • Boudreaux JP, Hayes DH, Mizrahi S, Maggiore P, Blazek J, Dick D. Decreasing incidence of serious cytomegalovirus infection using gancyclovir prophylaxis in pediatric liver transplant patients. Transplant Proc. 1993 Apr;25(2):1872–1872. [PubMed]
  • Bourlond A, Alexandre G. Dermal alternariasis in a kidney transplant recipient. Dermatologica. 1984;168(3):152–156. [PubMed]
  • Bouscarat F, Samuel D, Simon F, Debat P, Bismuth H, Saimot AG. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis. 1994 Nov;19(5):854–859. [PubMed]
  • Bowen PA, 2nd, Lobel SA, Caruana RJ, Leffell MS, House MA, Rissing JP, Humphries AL. Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production. Ann Intern Med. 1988 Jan;108(1):46–48. [PubMed]
  • Boyle EM, Jr, Burdine J, Bolman RM., 3rd Successful treatment of Mycoplasma mediastinitis after heart-lung transplantation. J Heart Lung Transplant. 1993 May-Jun;12(3):508–512. [PubMed]
  • Braf ZF, Altmann G, Ostfeld E. Fungal infections after renal transplantation. Isr J Med Sci. 1976 Jul;12(7):674–677. [PubMed]
  • Branger B, Gouby A, Oulès R, Balducchi JP, Mourad G, Fourcade J, Mion C, Duntz F, Ramuz M. Mycobacterium haemophilum and mycobacterium xenopi associated infection in a renal transplant patient. Clin Nephrol. 1985 Jan;23(1):46–49. [PubMed]
  • Brayman KL, Dafoe DC, Smythe WR, Barker CF, Perloff LJ, Naji A, Fox IJ, Grossman RA, Jorkasky DK, Starr SE, et al. Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial. Arch Surg. 1988 Dec;123(12):1502–1508. [PubMed]
  • Brayman KL, Stephanian E, Matas AJ, Schmidt W, Payne WD, Sutherland DE, Gores PF, Najarian JS, Dunn DL. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg. 1992 Jan;127(1):38–48. [PubMed]
  • Breinig MK, Zitelli B, Starzl TE, Ho M. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis. 1987 Aug;156(2):273–279. [PMC free article] [PubMed]
  • Brems JJ, Hiatt JR, Klein AS, Hart J, el-Khoury G, Winston D, Millis JM, Busuttil RW. Disseminated aspergillosis complicating orthotopic liver transplantation for fulminant hepatic failure refractory to corticosteroid therapy. Transplantation. 1988 Sep;46(3):479–481. [PubMed]
  • Bren A, Kandus A, Lindic J, Varl J. Fluconazole in the treatment of fungal infections in kidney-transplanted patients. Transplant Proc. 1992 Dec;24(6):2765–2766. [PubMed]
  • Brett MT, Kwan JT, Bending MR. Caecal perforation in a renal transplant patient with disseminated histoplasmosis. J Clin Pathol. 1988 Sep;41(9):992–995. [PMC free article] [PubMed]
  • Britt RH, Enzmann DR, Remington JS. Intracranial infection in cardiac transplant recipients. Ann Neurol. 1981 Feb;9(2):107–119. [PubMed]
  • Britt W, Fay J, Seals J, Kensil C. Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice. J Infect Dis. 1995 Jan;171(1):18–25. [PubMed]
  • Brooks RG, Hofflin JM, Jamieson SW, Stinson EB, Remington JS. Infectious complications in heart-lung transplant recipients. Am J Med. 1985 Oct;79(4):412–422. [PubMed]
  • Bubak ME, Porayko MK, Krom RA, Wiesner RH. Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology. 1991 Dec;14(6):1063–1065. [PubMed]
  • Buffington GA, Dominguez JH, Piering WF, Hebert LA, Kauffman HM, Jr, Lemann J., Jr Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA. 1976 Oct 25;236(17):1958–1960. [PubMed]
  • Buhles WC, Jr, Mastre BJ, Tinker AJ, Strand V, Koretz SH. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S495–S506. [PubMed]
  • Burdelski M, Schmidt K, Hoyer PF, Bernsau U, Galaske R, Brodehl J, Ringe B, Lauchart W, Wonigeit K, Pichlmayr R. Liver transplantation in children: the Hannover experience. Transplant Proc. 1987 Aug;19(4):3277–3281. [PubMed]
  • Burke EM, Karp DL, Wu TC, Corio RL. Atypical oral presentation of herpes simplex virus infection in a patient after orthotopic liver transplantation. Eur Arch Otorhinolaryngol. 1994;251(5):301–303. [PubMed]
  • Burkhart CG, Dvorak N, Stockard H. An unusual case of tinea versicolor in an immunosuppressed patient. Cutis. 1981;27(1):56–58. [PubMed]
  • Butka BJ, Bennett SR, Johnson AC. Disseminated inoculation blastomycosis in a renal transplant recipient. Am Rev Respir Dis. 1984 Dec;130(6):1180–1183. [PubMed]
  • Byl B, Jacobs F, Antoine M, Depierreux M, Serruys E, Primo G, Thys JP. Mediastinitis caused by Aspergillus fumigatus with ruptured aortic pseudoaneurysm in a heart transplant recipient: case study. Heart Lung. 1993 Mar-Apr;22(2):145–147. [PubMed]
  • Byrd BF, 3rd, Weiner MH, McGee ZA. Aspergillus spinal epidural abscess. JAMA. 1982 Dec 17;248(23):3138–3139. [PubMed]
  • Caccamo L, Colledan M, Gridelli B, Rossi G, Doglia M, Gatti S, Ghidoni P, Lucianetti A, Lunghi G, Maggi U, et al. Hepatitis C virus infection in liver allograft recipients. Arch Virol Suppl. 1993;8:291–304. [PubMed]
  • Cagle PT, Buffone G, Holland VA, Samo T, Demmler GJ, Noon GP, Lawrence EC. Semiquantitative measurement of cytomegalovirus DNA in lung and heart-lung transplant patients by in vitro DNA amplification. Chest. 1992 Jan;101(1):93–96. [PubMed]
  • Carbone KM, Pennington LR, Gimenez LF, Burrow CR, Watson AJ. Mucormycosis in renal transplant patients--a report of two cases and review of the literature. Q J Med. 1985 Dec;57(224):825–831. [PubMed]
  • Carrier M, Pelletier GB, Cartier R, Leclerc Y, Pelletier LC. Prevention of herpes simplex virus infection by oral acyclovir after cardiac transplantation. Can J Surg. 1992 Oct;35(5):513–516. [PubMed]
  • Carter JM, Green WR, Callender CO, Peters B. Pulmonary cavitation with Nocardia and Aspergillus in a renal transplant patient. J Natl Med Assoc. 1990 Jul;82(7):527–531. [PMC free article] [PubMed]
  • Castaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS, Langnas AN, Reed EC, Li SJ, Pillen TJ, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg. 1991 Feb;126(2):149–156. [PubMed]
  • Castaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS, Langnas AN, Reed EC, Li S, Pillen TJ, et al. Fungal disease in liver transplant recipients: a multivariate analysis of risk factors. Transplant Proc. 1991 Feb;23(1 Pt 2):1517–1519. [PubMed]
  • Castaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS, Langnas AN, Shaw BW., Jr Fungal infections in liver allograft recipients. Transplant Proc. 1991 Jun;23(3):1967–1967. [PubMed]
  • Castelli C, Benazzo F, Minoli L, Marone P, Seghezzi R, Carlizzi CN. Aspergillus infection of the L3-L4 disc space in an immunosuppressed heart transplant patient. Spine (Phila Pa 1976) 1990 Dec;15(12):1369–1373. [PubMed]
  • Caya JG, Farmer SG, Williams GA, Franson TR, Komorowski RA, Kies JC. Bilateral Pseudallescheria boydii endophthalmitis in an immunocompromised patient. Wis Med J. 1988 Mar;87(3):11–14. [PubMed]
  • Cerrina J, Bavoux E, Le Roy Ladurie F, Herve P, Lafont D, Simonneau G, Dartevelle P. Ganciclovir treatment of cytomegalovirus infection in heart-lung and double-lung transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1174–1175. [PubMed]
  • Chang H, Wu JD, Cheng KK, Tseng HH. Epstein-Barr virus-associated lymphoproliferative disorders in oral cavity after heart transplantation: report of a case. J Formos Med Assoc. 1994 Apr;93(4):332–336. [PubMed]
  • Chang RS, Lewis JP, Reynolds RD, Sullivan MJ, Neuman J. Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann Intern Med. 1978 Jan;88(1):34–40. [PubMed]
  • Chaparro C, Maurer JR, Chamberlain D, De Hoyos A, Winton T, Westney G, Kesten S. Causes of death in lung transplant recipients. J Heart Lung Transplant. 1994 Sep-Oct;13(5):758–766. [PubMed]
  • Chapman LE, Folks TM, Salomon DR, Patterson AP, Eggerman TE, Noguchi PD. Xenotransplantation and xenogeneic infections. N Engl J Med. 1995 Nov 30;333(22):1498–1501. [PubMed]
  • Chatterjee SN, Chang RS. A prospective study of oropharyngeal excretion of Epstein-Barr virus in renal homograft recipients. Scand J Infect Dis. 1982;14(2):95–98. [PubMed]
  • Chave JP, David S, Wauters JP, Van Melle G, Francioli P. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS. 1991 Aug;5(8):927–932. [PubMed]
  • Cheeseman SH, Rubin RH, Stewart JA, Tolkoff-Rubin NE, Cosimi AB, Cantell K, Gilbert J, Winkle S, Herrin JT, Black PH, et al. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med. 1979 Jun 14;300(24):1345–1349. [PubMed]
  • Chou SW. Cytomegalovirus infection and reinfection transmitted by heart transplantation. J Infect Dis. 1987 May;155(5):1054–1056. [PubMed]
  • Chugh KS, Sakhuja V, Jain S, Singh V, Tarafdar A, Joshi K, Gupta KL, Minz M. Fungal infections in renal allograft recipients. Transplant Proc. 1992 Oct;24(5):1940–1942. [PubMed]
  • Chugh KS, Sakhuja V, Jain S, Talwar P, Minz M, Joshi K, Indudhara R. High mortality in systemic fungal infections following renal transplantation in third-world countries. Nephrol Dial Transplant. 1993;8(2):168–172. [PubMed]
  • Cofer JB, Morris CA, Sutker WL, Husberg BS, Goldstein RM, Gonwa TA, Klintmalm GB. A randomized double-blind study of the effect of prophylactic immune globulin on the incidence and severity of CMV infection in the liver transplant recipient. Transplant Proc. 1991 Feb;23(1 Pt 2):1525–1527. [PubMed]
  • Cohen AT, O'Grady JG, Sutherland S, Sallie R, Tan KC, Williams R. Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults. J Med Virol. 1993 May;40(1):5–9. [PubMed]
  • Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med. 1982 Mar;142(3):489–494. [PubMed]
  • Cohen SG, Greenberg MS. Rhinomaxillary mucormycosis in a kidney transplant patient. Oral Surg Oral Med Oral Pathol. 1980 Jul;50(1):33–38. [PubMed]
  • Collins LA, Samore MH, Roberts MS, Luzzati R, Jenkins RL, Lewis WD, Karchmer AW. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis. 1994 Sep;170(3):644–652. [PubMed]
  • Colombo JL, Sammut PH, Langnas AN, Shaw BW., Jr The spectrum of Pneumocystis carinii infection after liver transplantation in children. Transplantation. 1992 Oct;54(4):621–624. [PubMed]
  • Colonna JO, 2nd, Winston DJ, Brill JE, Goldstein LI, Hoff MP, Hiatt JR, Quinones-Baldrich W, Ramming KP, Busuttil RW. Infectious complications in liver transplantation. Arch Surg. 1988 Mar;123(3):360–364. [PubMed]
  • Conces DJ, Jr, Vix VA, Tarver RD. Pleural cryptococcosis. J Thorac Imaging. 1990 Apr;5(2):84–86. [PubMed]
  • Conti DJ, Freed BM, Gruber SA, Lempert N. Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin. Arch Surg. 1994 Apr;129(4):443–447. [PubMed]
  • Conti DJ, Tolkoff-Rubin NE, Baker GP, Jr, Doran M, Cosimi AB, Delmonico F, Auchincloss H, Jr, Russell PS, Rubin RH. Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients. Transplantation. 1989 Oct;48(4):692–695. [PubMed]
  • Cooper DK, Novitzky D, Schlegel V, Muchmore JS, Cucchiara A, Zuhdi N. Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation. J Heart Lung Transplant. 1991 Sep-Oct;10(5 Pt 1):656–663. [PubMed]
  • Cooper JF, Lichtenstein MJ, Graham BS, Schaffner W. Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients. Am J Med. 1989 Feb;86(2):173–177. [PubMed]
  • Cortet B, Richard R, Deprez X, Lucet L, Flipo RM, Le Loët X, Duquesnoy B, Delcambre B. Aspergillus spondylodiscitis: successful conservative treatment in 9 cases. J Rheumatol. 1994 Jul;21(7):1287–1291. [PubMed]
  • Costa JM, Meyers AM, Botha JR, Conlan AA, Myburgh A. Mycobacterial infections in recipients of kidney allografts. A seventeen-year experience. Acta Med Port. 1988 Jan-Feb;1(1):51–57. [PubMed]
  • Coutts II, Jegarajah S, Stark JE. Tuberculosis in renal transplant recipients. Br J Dis Chest. 1979 Apr;73(2):141–148. [PubMed]
  • Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, Lennette ET, Martinez OM, Krams SM, Berquist WE, So SK, Esquivel CO. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation. 1995 Feb 27;59(4):524–529. [PubMed]
  • Crompton CH, Cheung RK, Donjon C, Miyazaki I, Feinmesser R, Hébert D, Dosch HM. Epstein-Barr virus surveillance after renal transplantation. Transplantation. 1994 Apr 27;57(8):1182–1189. [PubMed]
  • Cruz N, Ramírez-Muxó O, Bermúdez RH, Santiago-Delpín EA. Pulmonary infection with M. kansasii in a renal transplant patient. Nephron. 1980;26(4):187–188. [PubMed]
  • Cuende E, Barbadillo C, E-Mazzucchelli R, Isasi C, Trujillo A, Andréu JL. Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature. Semin Arthritis Rheum. 1993 Feb;22(4):224–241. [PubMed]
  • Cuervas-Mons V, Julio Martinez A, Dekker A, Starzl TE, Van Thiel DH. Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology. 1986 May-Jun;6(3):495–501. [PMC free article] [PubMed]
  • Cuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology. 1986 Sep-Oct;6(5):922–927. [PMC free article] [PubMed]
  • Da Cunha S, Ferreira E, Ramos I, Martins R, De Freitas L, Borges JL, Côrte-Real R, Mota A, Meliço-Silvestre A, Furtado AL. Cerebral toxoplasmosis after renal transplantation. Case report and review. Acta Med Port. 1994 Dec;7 (Suppl 1):S61–S66. [PubMed]
  • D'Alessandro AM, Pirsch JD, Stratta RJ, Sollinger HW, Kalayoglu M, Belzer FO. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients. Transplant Proc. 1989 Jun;21(3):3560–3561. [PubMed]
  • Daman LA, Hashimoto K, Kaplan RJ, Trent WG. Disseminated histoplasmosis in an immunosuppressed patient. South Med J. 1977 Mar;70(3):355–356. [PubMed]
  • Daoud S, Garnier JL, Chossegros P, Chevallier P, Dubernard JM, Touraine JL. Hepatitis C virus infection in renal transplantation. Transplant Proc. 1995 Apr;27(2):1735–1735. [PubMed]
  • Davies SF, Sarosi GA, Peterson PK, Khan M, Howard RJ, Simmons RL, Najarian JS. Disseminated histoplasmosis in renal transplant recipients. Am J Surg. 1979 May;137(5):686–691. [PubMed]
  • Davis BR, Brumbach J, Sanders WJ, Wolinsky E. Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med. 1982 Nov;97(5):723–724. [PubMed]
  • Davis CL, Gretch DR, Carithers RL., Jr Hepatitis B and transplantation. Infect Dis Clin North Am. 1995 Dec;9(4):925–941. [PubMed]
  • Davis CL, Springmeyer S, Gmerek BJ. Central nervous system side effects of ganciclovir. N Engl J Med. 1990 Mar 29;322(13):933–934. [PubMed]
  • Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Clin Transplant. 1995 Feb;9(1):53–59. [PubMed]
  • De Biase L, Venditti M, Gallo P, Macchiarelli A, Tonelli E, Scibilia G, Marino B. Herpes simplex pneumonia in a heart transplant recipient. Recenti Prog Med. 1992 Jun;83(6):341–343. [PubMed]
  • de Hemptinne B, Lamy ME, Salizzoni M, Cornu C, Mostin J, Fevery J, De Groote V, Otte JB. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine). Transplant Proc. 1988 Feb;20(1 Suppl 1):652–655. [PubMed]
  • de Koning J, van Dorp WT, van Es LA, van 't Wout JW, van der Woude FJ. Ganciclovir effectively treats cytomegalovirus disease after solid-organ transplantation, even during rejection treatment. Nephrol Dial Transplant. 1992;7(4):350–356. [PubMed]
  • de la Mata M, Rufián S, Gómez F, Varo E, López-Cillero P, Costán G, Solórzano G, González R, Miño G, Pera C. Recurrent fulminant liver failure caused by hepatitis B virus after liver transplantation. J Clin Gastroenterol. 1994 Oct;19(3):238–241. [PubMed]
  • Delaney V, Sumrani N, Hong JH, Sommer B. Mycobacterial infections in renal allograft recipients. Transplant Proc. 1993 Jun;25(3):2288–2289. [PubMed]
  • Delgado R, Lumbreras C, Alba C, Pedraza MA, Otero JR, Gómez R, Moreno E, Noriega AR, Payá CV. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol. 1992 Jul;30(7):1876–1878. [PMC free article] [PubMed]
  • Demetris AJ. Hepatitis B after liver transplantation: new names for unusual presentations. Gastroenterology. 1992 Oct;103(4):1355–1356. [PubMed]
  • Dennis C, Caine N, Sharples L, Smyth R, Higenbottam T, Stewart S, Wreghitt T, Large S, Wells FC, Wallwork J. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):893–902. [PubMed]
  • Deusch E, End A, Grimm M, Graninger W, Klepetko W, Wolner E. Early bacterial infections in lung transplant recipients. Chest. 1993 Nov;104(5):1412–1416. [PubMed]
  • DeVault GA, Jr, Brown ST, 3rd, Montoya SF, Jr, King JW, Rohr MS, McDonald JC. Disseminated strongyloidiasis complicating acute renal allograft rejection. Prolonged thiabendazole administration and successful retransplantation. Transplantation. 1982 Oct;34(4):220–221. [PubMed]
  • DeVault GA, Jr, King JW, Rohr MS, Landreneau MD, Brown ST, 3rd, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis. 1990 Jul-Aug;12(4):653–671. [PubMed]
  • De Vuyst D, Surmont I, Verhaegen J, Vanhaecke J. Tibial osteomyelitis due to Aspergillus flavus in a heart transplant patient. Infection. 1992 Jan-Feb;20(1):48–49. [PubMed]
  • Dhar JM, al-Khader AA, al-Sulaiman M, al-Hasani MK. Non-typhoid Salmonella in renal transplant recipients: a report of twenty cases and review of the literature. Q J Med. 1991 Mar;78(287):235–250. [PubMed]
  • Dodd LG, Nelson SD. Disseminated coccidioidomycosis detected by percutaneous liver biopsy in a liver transplant recipient. Am J Clin Pathol. 1990 Jan;93(1):141–144. [PubMed]
  • Dooley DP, Beckius ML, Jeffery BS, McAllister CK, Radentz WH, Feldman AR, Rinaldi MG, Bailey SR, Keeling JH. Phaeohyphomycotic cutaneous disease caused by Pleurophoma in a cardiac transplant patient. J Infect Dis. 1989 Mar;159(3):503–507. [PubMed]
  • Dowling JN, Pasculle AW, Frola FN, Zaphyr MK, Yee RB. Infections caused by Legionella micdadei and Legionella pneumophila among renal transplant recipients. J Infect Dis. 1984 May;149(5):703–713. [PubMed]
  • Dowling RD, Baladi N, Zenati M, Dummer JS, Kormos RL, Armitage JM, Yousem SA, Hardesty RL, Griffith BP. Disruption of the aortic anastomosis after heart-lung transplantation. Ann Thorac Surg. 1990 Jan;49(1):118–122. [PubMed]
  • Dreikorn K, Doerr HW, Geursen RG. Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG. Scand J Urol Nephrol Suppl. 1985;92:15–21. [PubMed]
  • Dummer JS. Pneumocystis carinii infections in transplant recipients. Semin Respir Infect. 1990 Mar;5(1):50–57. [PubMed]
  • Dummer JS, Armstrong J, Somers J, Kusne S, Carpenter BJ, Rosenthal JT, Ho M. Transmission of infection with herpes simplex virus by renal transplantation. J Infect Dis. 1987 Feb;155(2):202–206. [PubMed]
  • Dummer JS, Erb S, Breinig MK, Ho M, Rinaldo CR, Jr, Gupta P, Ragni MV, Tzakis A, Makowka L, Van Thiel D, et al. Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation. 1989 Jan;47(1):134–140. [PMC free article] [PubMed]
  • Dummer JS, Hardy A, Poorsattar A, Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation. 1983 Sep;36(3):259–267. [PubMed]
  • Dummer JS, Montero CG, Griffith BP, Hardesty RL, Paradis IL, Ho M. Infections in heart-lung transplant recipients. Transplantation. 1986 Jun;41(6):725–729. [PubMed]
  • Dummer S, Kusne S. Liver transplantation and related infections. Semin Respir Infect. 1993 Sep;8(3):191–198. [PubMed]
  • Duncan SR, Grgurich WF, Iacono AT, Burckart GJ, Yousem SA, Paradis IL, Williams PA, Johnson BA, Griffith BP. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med. 1994 Jul;150(1):146–152. [PubMed]
  • Duncan SR, Paradis IL, Dauber JH, Yousem SA, Hardesty RL, Griffith BP. Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1213–1215. [PubMed]
  • Dunn DL, Gillingham KJ, Kramer MA, Schmidt WJ, Erice A, Balfour HH, Jr, Gores PF, Gruessner RW, Matas AJ, Payne WD, et al. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation. 1994 Mar 27;57(6):876–884. [PubMed]
  • Dunn DL, Mayoral JL, Gillingham KJ, Loeffler CM, Brayman KL, Kramer MA, Erice A, Balfour HH, Jr, Fletcher CV, Bolman RM, 3rd, et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation. 1991 Jan;51(1):98–106. [PubMed]
  • Durand F, Bernuau J, Dupont B, Sauvanet A, Belghiti J, Degott C, Benhamou JP. Aspergillus intraabdominal abscess after liver transplantation successfully treated with itraconazole. Transplantation. 1992 Oct;54(4):734–735. [PubMed]
  • Dussaix E, Wood C. Cytomegalovirus infection in pediatric liver recipients. A virological survey and prophylaxis with CMV immune globulin and early DHPG treatment. Transplantation. 1989 Aug;48(2):272–274. [PubMed]
  • Duston M, McHenry MC, Braun WF, Fieker DH, Gavan TL, Novick AC. Cryptococcal meningitis causing fever of unknown origin in renal transplant recipients: report of two cases initially diagnosed by urine cultures. Transplantation. 1981 Oct;32(4):334–336. [PubMed]
  • Dyall-Smith D, Trowell H, Mark A, Dyall-Smith M. Cutaneous squamous cell carcinomas and papillomaviruses in renal transplant recipients: a clinical and molecular biological study. J Dermatol Sci. 1991 May;2(3):139–146. [PubMed]
  • Einsele H, Ehninger G, Steidle M, Vallbracht A, Müller M, Schmidt H, Saal JG, Waller HD, Müller CA. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet. 1991 Nov 9;338(8776):1170–1172. [PubMed]
  • Eisen HJ, Hicks D, Kant JA, Montone KT, Mull R, Pigott J, Tomaszewski JE. Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient. J Heart Lung Transplant. 1994 Mar-Apr;13(2):241–245. [PubMed]
  • Eisenmann D, Knipp H, Laube H, Stegmann T. Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir. Transplant Proc. 1990 Oct;22(5):2322–2323. [PubMed]
  • Elinder CG, Andersson J, Bolinder G, Tydén G. Effectiveness of low-dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation. Transpl Int. 1992 May;5(2):81–84. [PubMed]
  • Elkhammas EA, Henry ML, Tesi RJ, Mutabagani K, Bryan BA, Ferguson RM. Cytomegalovirus prevention in combined kidney-pancreas transplantation using acyclovir alone. Transplant Proc. 1994 Apr;26(2):436–436. [PubMed]
  • Elkins CC, Frist WH, Dummer JS, Stewart JR, Merrill WH, Carden KA, Bender HW., Jr Cytomegalovirus disease after heart transplantation: is acyclovir prophylaxis indicated? Ann Thorac Surg. 1993 Dec;56(6):1267–1273. [PubMed]
  • End A, Helbich T, Wisser W, Dekan G, Klepetko W. The pulmonary nodule after lung transplantation. Cause and outcome. Chest. 1995 May;107(5):1317–1322. [PubMed]
  • Erice A, Holm MA, Gill PC, Henry S, Dirksen CL, Dunn DL, Hillam RP, Balfour HH., Jr Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol. 1992 Nov;30(11):2822–2825. [PMC free article] [PubMed]
  • Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH., Jr Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA. 1987 Jun 12;257(22):3082–3087. [PubMed]
  • Erice A, Rhame FS, Heussner RC, Dunn DL, Balfour HH., Jr Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis. 1991 Jul-Aug;13(4):537–547. [PubMed]
  • Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF, Follansbee SE, Grant RM, Crumpacker CS. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1989 Feb 2;320(5):293–296. [PubMed]
  • Esquivel CO, Jaffe R, Gordon RD, Iwatsuki S, Shaw BW, Jr, Starzl TE. Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis. 1985 Nov;5(4):369–374. [PubMed]
  • Faggian G, Livi U, Bortolotti U, Mazzucco A, Stellin G, Chiominto B, Vivani MA, Gallucci V. Itraconazole therapy for acute invasive pulmonary aspergillosis in heart transplantation. Transplant Proc. 1989 Feb;21(1 Pt 3):2506–2507. [PubMed]
  • Fairley JW, Hunt BJ, Glover GW, Radley-Smith RC, Yacoub MH. Unusual lymphoproliferative oropharyngeal lesions in heart and heart-lung transplant recipients. J Laryngol Otol. 1990 Sep;104(9):720–724. [PubMed]
  • Farr B, Beacham BE, Atuk NO. Cutaneous histoplasmosis after renal transplantation. South Med J. 1981 May;74(5):635–637. [PubMed]
  • Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs. 1990 Apr;39(4):597–638. [PubMed]
  • Fehir KM, Decker WA, Samo T, Young JB, Lederer E, Lawrence EC. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation. Transplant Proc. 1989 Feb;21(1 Pt 3):3107–3109. [PubMed]
  • Féray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, Reynes M, Bréchot C, Bismuth H. The course of hepatitis C virus infection after liver transplantation. Hepatology. 1994 Nov;20(5):1137–1143. [PubMed]
  • Ferraz AS, Figueiredo JF. Transmission of Chagas' disease through transplanted kidney: occurrence of the acute form of the disease in two recipients from the same donor. Rev Inst Med Trop Sao Paulo. 1993 Sep-Oct;35(5):461–463. [PubMed]
  • Ferreiro JA, Robert MA, Townsend J, Vinters HV. Neuropathologic findings after liver transplantation. Acta Neuropathol. 1992;84(1):1–14. [PubMed]
  • Finkelstein R, Singer P, Lefler E. Catheter-related fungemia caused by trichosporon beigelii in non-neutropenic patients. Am J Med. 1989 Jan;86(1):133–133. [PubMed]
  • Finn WF. CMV-enriched immune globulin produces consistent reliable results in renal transplant patients. Transplantation. 1993 Aug;56(2):491–491. [PubMed]
  • Fisher J, Tuazon CU, Geelhoed GW. Mucormycosis in transplant patients. Am Surg. 1980 May;46(5):315–322. [PubMed]
  • Fishman JA. Pneumocystis carinii and parasitic infections in transplantation. Infect Dis Clin North Am. 1995 Dec;9(4):1005–1044. [PubMed]
  • Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med. 1994 Jun;149(6):1601–1607. [PubMed]
  • Fojtasek MF, Kelly MT. Isolation of Mycobacterium chelonei with the lysis-centrifugation blood culture technique. J Clin Microbiol. 1982 Aug;16(2):403–405. [PMC free article] [PubMed]
  • Forbes GM, Harvey FA, Philpott-Howard JN, O'Grady JG, Jensen RD, Sahathevan M, Casewell MW, Williams R. Nocardiosis in liver transplantation: variation in presentation, diagnosis and therapy. J Infect. 1990 Jan;20(1):11–19. [PubMed]
  • Fowler CG, Lindsay I, Levin J, Sweny P, Fernando ON, Moorhead JF. Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) 1982 Nov 13;285(6352):1394–1394. [PMC free article] [PubMed]
  • Fox AS, Tolpin MD, Baker AL, Broelsch CE, Whittington PF, Jackson T, Thistlethwaite JR, Stuart FP. Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis. 1988 Feb;157(2):383–385. [PubMed]
  • Fox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med. 1990 Sep;89(3):255–274. [PubMed]
  • Fraser DW, Buxton AE, Naji A, Barker CF, Rudnick M, Weinstein AJ. Disseminated mycobacterium kansasii infection presenting as cellulitis in a recipient of a renal homograft. Am Rev Respir Dis. 1975 Jul;112(1):125–129. [PubMed]
  • Freise CE, Pons V, Lake J, Burke E, Ascher NL, Roberts JP. Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1498–1500. [PubMed]
  • Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DE, Najarian JS. Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation. 1992 Jul;54(1):50–56. [PubMed]
  • Frick T, Fryd DS, Goodale RL, Simmons RL, Sutherland DE, Najarian JS. Incidence and treatment of candida esophagitis in patients undergoing renal transplantation. Data from the Minnesota prospective randomized trial of cyclosporine versus antilymphocyte globulin-azathioprine. Am J Surg. 1988 Feb;155(2):311–313. [PubMed]
  • Gallis HA, Berman RA, Cate TR, Hamilton JD, Gunnells JC, Stickel DL. Fungal infection following renal transplantation. Arch Intern Med. 1975 Sep;135(9):1163–1172. [PubMed]
  • Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996 Mar 28;334(13):815–820. [PubMed]
  • Garnier JL, Berger F, Betuel H, Vuillaume M, Chapuis-Cellier C, Blanc N, Faure JL, Dubernard JM, Lenoir G, Touraine JL. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation. Nephrol Dial Transplant. 1989;4(9):818–823. [PubMed]
  • Gelpi J, Chernoff A, Snydman D, Freeman RB, Rohrer RJ, Haug CE. Aspergillus brain abscess after liver transplantation with long-term survival. A case report. Transplantation. 1994 Jun 15;57(11):1669–1672. [PubMed]
  • George DL, Arnow PM, Fox A, Thistlethwaite JR, Emond JC, Broelsch CE, Whitington PF. Patterns of infection after pediatric liver transplantation. Am J Dis Child. 1992 Aug;146(8):924–929. [PubMed]
  • George DL, Arnow PM, Fox AS, Baker AL, Thistlethwaite JR, Emond JC, Whitington PF, Broelsch CE. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis. 1991 May-Jun;13(3):387–396. [PubMed]
  • Gershon AA. Immunizations for pediatric transplant patients. Kidney Int Suppl. 1993 Oct;43:S87–S90. [PubMed]
  • Glazer JP, Friedman HM, Grossman RA, Starr SE, Barker CF, Perloff LJ, Huang ES, Plotkin SA. Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial. Ann Intern Med. 1979 Nov;91(5):676–683. [PubMed]
  • Glowacki LS, Smaill FM. Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis. Clin Transplant. 1994 Feb;8(1):10–18. [PubMed]
  • Goffin E, Pirson Y, Cornu C, Geubel A, Squifflet JP, van Ypersele de Strihou C. Outcome of HCV infection after renal transplantation. Kidney Int. 1994 Feb;45(2):551–555. [PubMed]
  • Gombert ME, Goldstein EJ, Corrado ML, Stein AJ, Butt KM. Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med. 1981 Apr;94(4 Pt 1):486–487. [PubMed]
  • Goodman JL. Possible transmission of herpes simplex virus by organ transplantation. Transplantation. 1989 Apr;47(4):609–613. [PubMed]
  • Gootenberg JE, Stewart CL, Vetro SW, Bellanti JA. Lack of graft rejection in a renal transplant recipient with AIDS. Ann Allergy. 1991 Aug;67(2 Pt 1):123–125. [PubMed]
  • Gordon SM, Gal AA, Hertzler GL, Bryan JA, Perlino C, Kanter KR. Diagnosis of pulmonary toxoplasmosis by bronchoalveolar lavage in cardiac transplant recipients. Diagn Cytopathol. 1993 Dec;9(6):650–654. [PubMed]
  • Gorensek MJ, Carey WD, Vogt D, Goormastic M. A multivariate analysis of risk factors for cytomegalovirus infection in liver-transplant recipients. Gastroenterology. 1990 May;98(5 Pt 1):1326–1332. [PubMed]
  • Gorensek MJ, Carey WD, Washington JA, 2nd, Vogt DP, Broughan TA, Westveer MK. Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients. Cleve Clin J Med. 1993 Mar-Apr;60(2):139–144. [PubMed]
  • Gouby A, Branger B, Oules R, Ramuz M. Two cases of Mycobacterium haemophilum infection in a renal-dialysis unit. J Med Microbiol. 1988 Apr;25(4):299–300. [PubMed]
  • Gould FK, Freeman R, Taylor CE, Ashcroft T, Dark JH, Corris PA. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center. J Heart Lung Transplant. 1993 Jul-Aug;12(4):695–699. [PubMed]
  • Graham DA, Kinyoun JL, George DP. Endogenous Aspergillus endophthalmitis after lung transplantation. Am J Ophthalmol. 1995 Jan;119(1):107–109. [PubMed]
  • Granier F, Kanitakis J, Hermier C, Zhu YY, Thivolet J. Localized cutaneous cryptococcosis successfully treated with ketoconazole. J Am Acad Dermatol. 1987 Jan;16(1 Pt 2):243–249. [PubMed]
  • Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs. 1989 Mar;37(3):310–344. [PubMed]
  • Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989 Jun 23;261(24):3561–3566. [PubMed]
  • Grauhan O, Lohmann R, Lemmens P, Schattenfroh N, Jonas S, Keck H, Raakow R, Langrehr J, Bechstein W, Blumhardt G, et al. Mycobacterial infection after liver transplantation. Langenbecks Arch Chir. 1995;380(3):171–175. [PubMed]
  • Grauhan O, Lohmann R, Lemmens P, Schattenfroh N, Keck H, Klein E, Raakow R, Jonas S, Langrehr JM, Bechstein W, et al. Fungal infections in liver transplant recipients. Langenbecks Arch Chir. 1994;379(6):372–375. [PubMed]
  • Gray J, Wreghitt TG, Pavel P, Smyth RL, Parameshwar J, Stewart S, Cary N, Large S, Wallwork J. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. J Heart Lung Transplant. 1995 Jul-Aug;14(4):640–646. [PubMed]
  • Graybill JR, Silva J, Jr, Fraser DW, Lordon R, Rogers E. Disseminated mycobacteriosis due to Mycobacterium abcessus in two recipients of renal homografts. Am Rev Respir Dis. 1974 Jan;109(1):4–10. [PubMed]
  • Green M, Reyes J, Nour B, Beatty D, Kaufman M, Wilson J, Todo S, Tzakis A. Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis. Transplant Proc. 1994 Feb;26(1):173–174. [PubMed]
  • Green M, Shlaes JH, Barbadora K, Shlaes DM. Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin Infect Dis. 1995 Mar;20(3):712–714. [PubMed]
  • Green M, Wald ER, Fricker FJ, Griffith BP, Trento A. Infections in pediatric orthotopic heart transplant recipients. Pediatr Infect Dis J. 1989 Feb;8(2):87–93. [PubMed]
  • Green M, Wald ER, Tzakis A, Todo S, Starzl TE. Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. Rev Infect Dis. 1991 Jul-Aug;13(4):653–657. [PMC free article] [PubMed]
  • Greene NB, Baughman RP, Kim CK, Roselle GA. Failure of ketoconazole in an immunosuppressed patient with pulmonary blastomycosis. Chest. 1985 Oct;88(4):640–641. [PubMed]
  • Grekas D, Alivanis P, Kiriazopoulou V, Dioudis C, Sioulis A, Derveniotis V, Tourkantonis A. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol. 1993 Nov;31(11):553–556. [PubMed]
  • Gribetz AR, Chuang MT, Burrows L, Teirstein AS. Rhizopus lung abscess in renal transplant patient successfully treated by lobectomy. Chest. 1980 Jan;77(1):102–104. [PubMed]
  • Griffith BP, Bando K, Hardesty RL, Armitage JM, Keenan RJ, Pham SM, Paradis IL, Yousem SA, Komatsu K, Konishi H, et al. A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. Transplantation. 1994 Mar 27;57(6):848–851. [PMC free article] [PubMed]
  • Grose C, Henle W, Horwitz MS. Primary Epstein-Barr virus infection in a renal transplant recipient. South Med J. 1977 Nov;70(11):1276–1278. [PubMed]
  • Grossi P, De Maria R, Caroli A, Zaina MS, Minoli L. Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation. J Heart Lung Transplant. 1992 Sep-Oct;11(5):847–866. [PubMed]
  • Grossi P, Ippoliti GB, Goggi C, Cremaschi P, Scaglia M, Minoli L. Pneumocystis carinii pneumonia in heart transplant recipients. Infection. 1993 Mar-Apr;21(2):75–79. [PubMed]
  • Grossi P, Revello MG, Minoli L, Percivalle E, Zavattoni M, Poma G, Martinelli L, Gerna G. Three-year experience with human cytomegalovirus infections in heart transplant recipients. J Heart Transplant. 1990 Nov-Dec;9(6):712–719. [PubMed]
  • Grundmann R, Wienand P, Runde A, Baldamus CA, Arns W, Burkhardt U. CMV-Hyperimmunoglobulinprophylaxe nach Nierentransplantation. Ergebnisse einer prospektiv randomisierten Studie. Dtsch Med Wochenschr. 1987 May 22;112(21):827–831. [PubMed]
  • Gryzan S, Paradis IL, Zeevi A, Duquesnoy RJ, Dummer JS, Griffith BP, Hardesty RL, Trento A, Nalesnik MA, Dauber JH. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis. 1988 Jun;137(6):1268–1274. [PubMed]
  • Gudnason T, Belani KK, Balfour HH., Jr Ganciclovir treatment of cytomegalovirus disease in immunocompromised children. Pediatr Infect Dis J. 1989 Jul;8(7):436–440. [PubMed]
  • Guerin C, Pozzetto B, Broyet C, Gaudin O, Berthoux F. Ganciclovir therapy of symptomatic cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant. 1989;4(10):906–910. [PubMed]
  • Guettier C, Hamilton-Dutoit S, Guillemain R, Farge D, Amrein C, Vulser C, Hofman P, Carpentier A, Diebold J. Primary gastrointestinal malignant lymphomas associated with Epstein-Barr virus after heart transplantation. Histopathology. 1992 Jan;20(1):21–28. [PubMed]
  • Guillemain R, Lavarde V, Amrein C, Chevalier P, Guinvarc'h A, Glotz D. Invasive aspergillosis after transplantation. Transplant Proc. 1995 Feb;27(1):1307–1309. [PubMed]
  • Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis. 1987 Mar-Apr;9(2):369–375. [PubMed]
  • Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH., Jr Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis. 1983 Aug;148(2):230–238. [PubMed]
  • Haagsma EB, Klompmaker IJ, Grond J, Bijleveld CM, The TH, Schirm J, Gips CH, Slooff MJ. Herpes virus infections after orthotopic liver transplantation. Transplant Proc. 1987 Oct;19(5):4054–4056. [PubMed]
  • Hachisuka H, Matsumoto T, Kusuhara M, Nomura H, Nakano S, Sasai Y. Cutaneous phaeohyphomycosis caused by Exophiala jeanselmei after renal transplantation. Int J Dermatol. 1990 Apr;29(3):198–200. [PubMed]
  • Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation. 1995 Mar 27;59(6):851–859. [PubMed]
  • Haim S, Better OS, Lichtig C, Erlik D, Barzilai A. Rhinocerebral mucormycosis following kidney transplantation. Isr J Med Sci. 1970 Sep-Oct;6(5):646–649. [PubMed]
  • Hall JC, Brewer JH, Crouch TT, Watson KR. Cryptococcal cellulitis with multiple sites of involvement. J Am Acad Dermatol. 1987 Aug;17(2 Pt 2):329–332. [PubMed]
  • Hall JC, Brewer JH, Reed WA, Steinhaus DM, Watson KR. Cutaneous mucormycosis in a heart transplant patient. Cutis. 1988 Sep;42(3):183–186. [PubMed]
  • Hall KA, Copeland JG, Zukoski CF, Sethi GK, Galgiani JN. Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection. Transplantation. 1993 Jun;55(6):1422–1424. [PubMed]
  • Hall KA, Sethi GK, Rosado LJ, Martinez JD, Huston CL, Copeland JG. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant. 1993 May-Jun;12(3):525–526. [PubMed]
  • Hall WA, Martinez AJ, Dummer JS, Griffith BP, Hardesty RL, Bahnson HT, Lunsford LD. Central nervous system infections in heart and heart-lung transplant recipients. Arch Neurol. 1989 Feb;46(2):173–177. [PubMed]
  • Hall WA, Martinez AJ, Dummer JS, Lunsford LD. Nocardial brain abscess: diagnostic and therapeutic use of stereotactic aspiration. Surg Neurol. 1987 Aug;28(2):114–118. [PubMed]
  • Hamdy NA, Andrew SM, Shortland JR, Boletis J, Raftery AT, Kanis JA, Brown CB. Fatal cardiac zygomycosis in a renal transplant patient treated with desferrioxamine. Nephrol Dial Transplant. 1989;4(10):911–913. [PubMed]
  • Hammer GS, Bottone EJ, Hirschman SZ. Mucormycosis in a transplant recipient. Am J Clin Pathol. 1975 Sep;64(3):389–398. [PubMed]
  • Hanto DW. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med. 1995;46:381–394. [PubMed]
  • Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH, Jr, Simmons RL, Najarian JS. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med. 1982 Apr 15;306(15):913–918. [PubMed]
  • Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res. 1981 Nov;41(11 Pt 1):4253–4261. [PubMed]
  • Haramati LB, Schulman LL, Austin JH. Lung nodules and masses after cardiac transplantation. Radiology. 1993 Aug;188(2):491–497. [PubMed]
  • Harbison MA, De Girolami PC, Jenkins RL, Hammer SM. Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients. Transplantation. 1988 Jul;46(1):82–88. [PubMed]
  • Hardy AM, Wajszczuk CP, Suffredini AF, Hakala TR, Ho M. Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis. 1984 Feb;149(2):143–147. [PubMed]
  • Harland RC, Vernon WB, Bunzendahl H, Thompson JK, Lawrence C, Bollinger RR. Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients. Transplant Proc. 1994 Apr;26(2):432–433. [PubMed]
  • Harris LF, Dan BM, Lefkowitz LB, Jr, Alford RH. Paecilomyces cellulitis in a renal transplant patient: successful treatment with intravenous miconazole. South Med J. 1979 Jul;72(7):897–898. [PubMed]
  • Havel MP, Laczkovics AM, Wolner E, Kurz RW, Popow-Kraupp T. Prophylactic use of hyperimmunoglobulin for cytomegalovirus infection in heart transplantation. Clin Ther. 1989 Jul-Aug;11(4):472–478. [PubMed]
  • Hayes MJ, Torzillo PJ, Sheil AG, McCaughan GW. Pneumocystis carinii pneumonia after liver transplantation in adults. Clin Transplant. 1994 Dec;8(6):499–503. [PubMed]
  • Heaton A, Arze RS, Ward MK. Acyclovir for life-threatening herpes simplex virus infection after renal transplantation. Lancet. 1981 Oct 17;2(8251):875–875. [PubMed]
  • Heironimus JD, Winn RE, Collins CB. Cutaneous nonpulmonary Mycobacterium chelonei infection. Successful treatment with sulfonamides in an immunosuppressed patient. Arch Dermatol. 1984 Aug;120(8):1061–1063. [PubMed]
  • Hellman RN, Hinrichs J, Sicard G, Hoover R, Golden P, Hoffsten P. Cryptococcal pyelonephritis and disseminated cryptococcosis in a renal transplant recipient. Arch Intern Med. 1981 Jan;141(1):128–130. [PubMed]
  • Henriquez M, Levy R, Raja RM, Kramer MS, Rosenbaum JL. Mucormycosis in a renal transplant recipient with successful outcome. JAMA. 1979 Sep 28;242(13):1397–1399. [PubMed]
  • Hesse UJ, Sutherland DE, Simmons RL, Najarian JS. Intra-abdominal infections in pancreas transplant recipients. Ann Surg. 1986 Feb;203(2):153–162. [PubMed]
  • Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis. 1994 Aug;19 (Suppl 1):S33–S40. [PubMed]
  • Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, Snydman DR, Freeman R, Lorber MI, Rubin RH. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 1;123(1):18–26. [PubMed]
  • Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, Schooley RT, Isaacson D, Doran M, Delvecchio A, Delmonico FL, Auchincloss H, Jr, Rubin RH. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation. 1992 Jan;53(1):68–72. [PubMed]
  • Higgins RM, Bloom SL, Hopkin JM, Morris PJ. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation. 1989 Mar;47(3):558–560. [PubMed]
  • Higgins RM, Cahn AP, Porter D, Richardson AJ, Mitchell RG, Hopkin JM, Morris PJ. Mycobacterial infections after renal transplantation. Q J Med. 1991 Feb;78(286):145–153. [PubMed]
  • Hii JH, Legault L, DeVeber G, Vas SI. Successful treatment of systemic blastomycosis with high-dose ketoconazole in a renal transplant recipient. Am J Kidney Dis. 1990 Jun;15(6):595–597. [PubMed]
  • Hirsch MS, Schooley RT, Cosimi AB, Russell PS, Delmonico FL, Tolkoff-Rubin NE, Herrin JT, Cantell K, Farrell ML, Rota TR, et al. Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med. 1983 Jun 23;308(25):1489–1493. [PubMed]
  • Hirschl MM, Derfler K, Janata O, Heinz G, Sertl K, Balcke P. Accumulation of pneumocystis carinii pneumonia in patients after kidney transplantation. Clin Nephrol. 1992 Feb;37(2):105–105. [PubMed]
  • Hirschmann JV, Plorde JJ, Ochi RF. Fever and pulmonary infiltrates in a patient with a renal transplant. West J Med. 1984 Jun;140(6):914–920. [PMC free article] [PubMed]
  • Ho M. Advances in understanding cytomegalovirus infection after transplantation. Transplant Proc. 1994 Oct;26(5 Suppl 1):7–11. [PubMed]
  • Hoepelman IM, Bakker LJ, Jessurun RF, Rozenberg-Arska M, Verhoef J. Disseminated Nocardia asteroides infection complicating renal transplantation. Neth J Med. 1987 Oct;31(3-4):175–182. [PubMed]
  • Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med. 1987 Feb;106(2):209–216. [PubMed]
  • Holden FA, Kaczmer JE, Kinahan CC. Listerial meningitis and renal allografts: a life-threatening affinity. Postgrad Med. 1980 Dec;68(6):69–74. [PubMed]
  • Hoon V, Fasy TM, Kheiri S, Theise N, Lin CS, Klion F, Schwartz M, Miller C, Thung SN. Case report: fatal lymphoproliferative disease seven weeks after liver transplantation. Mt Sinai J Med. 1994 Jan;61(1):72–76. [PubMed]
  • HOPE-SIMPSON RE. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med. 1965 Jan;58:9–20. [PMC free article] [PubMed]
  • Hopt UT, Pfeffer F, Schareck W, Büsing M, Ming C. Ganciclovir for prophylaxis of CMV disease after pancreas/kidney transplantation. Transplant Proc. 1994 Apr;26(2):434–435. [PubMed]
  • Hornef MW, Bein G, Fricke L, Steinhoff J, Wagner HJ, Hinderer W, Sonneborn HH, Kirchner H. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation. 1995 Sep 15;60(5):474–480. [PubMed]
  • Horton CM, Freeman CD, Nolan PE, Jr, Copeland JG., 3rd Cyclosporine interactions with miconazole and other azole-antimycotics: a case report and review of the literature. J Heart Lung Transplant. 1992 Nov-Dec;11(6):1127–1132. [PubMed]
  • Horvath J, Dummer S, Loyd J, Walker B, Merrill WH, Frist WH. Infection in the transplanted and native lung after single lung transplantation. Chest. 1993 Sep;104(3):681–685. [PubMed]
  • Howard RJ, Simmons RL, Najarian JS. Fungal infections in renal transplant recipients. Ann Surg. 1978 Nov;188(5):598–605. [PubMed]
  • Hoy WE, Roberts NJ, Jr, Bryson MF, Bowles C, Lee JC, Rivero AJ, Ritterson AL. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA. 1981 Oct 23;246(17):1937–1939. [PubMed]
  • Hrebinko R, Jordan ML, Dummer JS, Hickey DP, Shapiro R, Vivas C, Starzl TE, Simmons RL, Hakala TR. Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1346–1347. [PMC free article] [PubMed]
  • Huang JY, Huang CC, Lai MK, Chu SH, Chuang CK. Salmonella infection in renal transplant recipients. Transplant Proc. 1994 Aug;26(4):2147–2147. [PubMed]
  • Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation--is it reversible? Transplantation. 1991 May;51(5):1004–1010. [PubMed]
  • Hubscher SG, Williams A, Davison SM, Young LS, Niedobitek G. Epstein-Barr virus in inflammatory diseases of the liver and liver allografts: an in situ hybridization study. Hepatology. 1994 Oct;20(4 Pt 1):899–907. [PubMed]
  • Hummel M, Schüler S, Hempel S, Rees W, Hetzer R. Obstructive bronchial aspergillosis after heart transplantation. Mycoses. 1993 Nov-Dec;36(11-12):425–428. [PubMed]
  • Hummel M, Schüler S, Weber U, Schwertlick G, Hempel S, Theiss D, Rees W, Mueller J, Hetzer R. Aspergillosis with Aspergillus osteomyelitis and diskitis after heart transplantation: surgical and medical management. J Heart Lung Transplant. 1993 Jul-Aug;12(4):599–603. [PubMed]
  • Hummel M, Thalmann U, Jautzke G, Staib F, Seibold M, Hetzer R. Fungal infections following heart transplantation. Mycoses. 1992 Jan-Feb;35(1-2):23–34. [PubMed]
  • Humphreys H, Marshall RJ, Mackay I, Caul EO. Pneumonia due to Legionella bozemanii and Chlamydia psittaci/TWAR following renal transplantation. J Infect. 1992 Jul;25(1):67–71. [PubMed]
  • Iacobellis FW, Jacobs MI, Cohen RP. Primary cutaneous cryptococcosis. Arch Dermatol. 1979 Aug;115(8):984–985. [PubMed]
  • Iberer F, Halwachs-Baumann G, Rödl S, Pleisnitzer A, Wasler A, Auer T, Petutschnigg B, Müller H, Tscheliessnigg K, Wilders-Truschnig M. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies. J Heart Lung Transplant. 1994 May-Jun;13(3):405–411. [PubMed]
  • Icenogle TB, Peterson E, Ray G, Minnich L, Copeland JG. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report. J Heart Transplant. 1987 Jul-Aug;6(4):199–203. [PubMed]
  • Indudhara R, Singh SK, Minz M, Yadav RV, Chugh KS. Tuberculous pyomyositis in a renal transplant recipient. Tuber Lung Dis. 1992 Aug;73(4):239–241. [PubMed]
  • Ingwer I, McLeish KR, Tight RR, White AC. Aspergillus fumigatus epidural abscess in a renal transplant recipient. Arch Intern Med. 1978 Jan;138(1):153–154. [PubMed]
  • Ireton RC, Krieger JN, Rudd TG, Marchioro TL. Percutaneous endoscopic treatment of fungus ball obstruction in a renal allograft. Transplantation. 1985 Apr;39(4):453–454. [PubMed]
  • Jaccard A, Emile JF, Metivier F, Clauvel JP, d'Agay MF. Epstein-Barr virus-associated Hodgkin's disease following renal transplantation. Am J Hematol. 1994 Jul;46(3):256–257. [PubMed]
  • Jacobs F, Byl B, Bourgeois N, Coremans-Pelseneer J, Florquin S, Depré G, Van de Stadt J, Adler M, Gelin M, Thys JP. Trichoderma viride infection in a liver transplant recipient. Mycoses. 1992 Nov-Dec;35(11-12):301–303. [PubMed]
  • Jacobs F, Van de Stadt J, Gelin M, Nonhoff C, Gay F, Adler M, Thys JP. Mycoplasma hominis infection of perihepatic hematomas in a liver transplant recipient. Surgery. 1992 Jan;111(1):98–100. [PubMed]
  • Jacobs F, Van de Stadt J, Bourgeois N, Struelens MJ, De Prez C, Adler M, Thys JP, Gelin M. Severe infections early after liver transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):2271–2273. [PubMed]
  • Jamieson SW, Stinson EB, Oyer PE, Reitz BA, Baldwin J, Modry D, Dawkins K, Theodore J, Hunt S, Shumway NE. Heart-lung transplantation for irreversible pulmonary hypertension. Ann Thorac Surg. 1984 Dec;38(6):554–562. [PubMed]
  • Janner D, Bork J, Baum M, Chinnock R. Severe pneumonia after heart transplantation as a result of human parvovirus B19. J Heart Lung Transplant. 1994 Mar-Apr;13(2):336–338. [PubMed]
  • Jennings HS, 3rd, Bradsher RW, McGee ZA, Johnson HK, Alford RH. Acute cryptococcal cellulitis in renal transplant recipients. South Med J. 1981 Sep;74(9):1150–1153. [PubMed]
  • Jensen WA, Rose RM, Hammer SM, Jenkins RL, Bothe A, Jr, Benotti PN, Dzik WH, Costello P, Khettry U, Trey C, et al. Pulmonary complications of orthotopic liver transplantation. Transplantation. 1986 Nov;42(5):484–490. [PubMed]
  • Jernigan DB, Sanders LI, Waites KB, Brookings ES, Benson RF, Pappas PG. Pulmonary infection due to Legionella cincinnatiensis in renal transplant recipients: two cases and implications for laboratory diagnosis. Clin Infect Dis. 1994 Mar;18(3):385–389. [PubMed]
  • Johnson BL. Intraocular and central nervous system lymphoma in a cardiac transplant recipient. Ophthalmology. 1992 Jun;99(6):987–992. [PubMed]
  • Jordan ML, Hrebinko RL, Jr, Dummer JS, Hickey DP, Shapiro R, Vivas CA, Simmons RL, Starzl TE, Hakala TR. Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. J Urol. 1992 Nov;148(5):1388–1392. [PMC free article] [PubMed]
  • Joshi SN, Garvin PJ, Sunwoo YC. Candidiasis of the duodenum and jejunum. Gastroenterology. 1981 Apr;80(4):829–833. [PubMed]
  • Kaden J, Scholz D, Eichler C, May G. Infektionshäufigkeit mit Zytomegalieviren (CMV) nach Nierentransplantation und erste Erfahrungen mit der CMV-Gammaglobulinprophylaxe. Immun Infekt. 1985 Nov;13(6):290–295. [PubMed]
  • Kaplan AH, Poza-Juncal E, Shapiro R, Stapleton JT. Cure of mucormycosis in a renal transplant patient receiving ciclosporin with maintenance of immunosuppression. Am J Nephrol. 1988;8(2):139–142. [PubMed]
  • Kaplan JE, Zoschke D, Kisch AL. Withdrawal of immunosuppresive agents in the treatment of disseminated coccidioidomycosis. Am J Med. 1980 Apr;68(4):624–628. [PubMed]
  • Kasiske BL, Heim-Duthoy KL, Tortorice KL, Ney AL, Odland MD, Rao KV. Polyvalent immune globulin and cytomegalovirus infection after renal transplantation. Arch Intern Med. 1989 Dec;149(12):2733–2736. [PubMed]
  • Katz NM, Pierce PF, Anzeck RA, Visner MS, Canter HG, Foegh ML, Pearle DL, Tracy C, Rahman A. Liposomal amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient. J Heart Transplant. 1990 Jan-Feb;9(1):14–17. [PubMed]
  • Keane WM, Potsic WP, Perloff LJ, Barker CF, Grossman RA. Aspergillus thyroiditis. Otolaryngology. 1978 Sep-Oct;86(5):ORL–761-5. [PubMed]
  • Keating MR. Antiviral agents. Mayo Clin Proc. 1992 Feb;67(2):160–178. [PubMed]
  • Keay S, Petersen E, Icenogle T, Zeluff BJ, Samo T, Busch D, Newman CL, Buhles WC, Jr, Merigan TC. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S563–S572. [PubMed]
  • Keenan RJ, Konishi H, Kawai A, Paradis IL, Nunley DR, Iacono AT, Hardesty RL, Weyant RJ, Griffith BP. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg. 1995 Sep;60(3):580–585. [PubMed]
  • Kendall TJ, Wilson JE, Radio SJ, Kandolf R, Gulizia JM, Winters GL, Costanzo-Nordin MR, Malcom GT, Thieszen SL, Miller LW, et al. Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts? J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 2):S14–S20. [PubMed]
  • Khawand N, Light JA, Brems W, Aquino A, Ali A. Does intravenous immunoglobulin prevent primary cytomegalovirus disease in kidney transplant recipients? Transplant Proc. 1989 Feb;21(1 Pt 2):2072–2074. [PubMed]
  • Kim JH, Perfect JR. Infection and cyclosporine. Rev Infect Dis. 1989 Sep-Oct;11(5):677–690. [PubMed]
  • Kinder RB, Jourdan MH. Disseminated aspergillosis and bleeding colonic ulcers in renal transplant patient. J R Soc Med. 1985 Apr;78(4):338–339. [PMC free article] [PubMed]
  • King D, Pasarell L, Dixon DM, McGinnis MR, Merz WG. A phaeohyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy. J Clin Microbiol. 1993 Jul;31(7):1804–1810. [PMC free article] [PubMed]
  • Kirchhoff LV. American trypanosomiasis (Chagas' disease)--a tropical disease now in the United States. N Engl J Med. 1993 Aug 26;329(9):639–644. [PubMed]
  • Kirklin JK, Naftel DC, Levine TB, Bourge RC, Pelletier GB, O'Donnell J, Miller LW, Pritzker MR. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994 May-Jun;13(3):394–404. [PubMed]
  • Kish LS, Taylor JS, Bergfeld WF, Hall GS. Petriellidium (Allescheria) boydii mycetoma in an immunosuppressed host. Cleve Clin Q. 1983 Summer;50(2):209–211. [PubMed]
  • Kitai IC, King S, Gafni A. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients. Clin Infect Dis. 1993 Sep;17(3):441–447. [PubMed]
  • Kiyasu PK, Ishitani MB, McGory RW, Gaffey MJ, Dickson RC, Caldwell SH, Stevenson WS, Pruett TL. Prevention of hepatitis B "rerecurrence" after a second liver transplant--the role of maintenance polyclonal HBIG therapy. Transplantation. 1994 Oct 27;58(8):954–956. [PubMed]
  • Kizilisik TA, Preiksaitis JK, Kneteman NM. Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis. Transplant Proc. 1993 Jun;25(3):2282–2283. [PubMed]
  • Klintmalm G, Lönnqvist B, Oberg B, Gahrton G, Lernestedt JO, Lundgren G, Ringdén O, Robert KH, Wahren B, Groth CG. Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis. 1985;17(2):157–163. [PubMed]
  • Kochhar R, Indudhara R, Nagi B, Yadav RV, Mehta SK. Colonic tuberculosis due to atypical mycobacteria in a renal transplant recipient. Am J Gastroenterol. 1988 Dec;83(12):1435–1436. [PubMed]
  • Koizumi JH, Sommers HM. Mycobacterium xenopi and pulmonary disease. Am J Clin Pathol. 1980 Jun;73(6):826–830. [PubMed]
  • Kolbeck PC, Makhoul RG, Bollinger RR, Sanfilippo F. Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. Am J Clin Pathol. 1985 Jun;83(6):747–753. [PubMed]
  • Kong NC, Shaariah W, Morad Z, Suleiman AB, Wong YH. Cryptococcosis in a renal unit. Aust N Z J Med. 1990 Oct;20(5):645–649. [PubMed]
  • Koranda FC, Dehmel EM, Kahn G, Penn I. Cutaneous complications in immunosuppressed renal homograft recipients. JAMA. 1974 Jul 22;229(4):419–424. [PubMed]
  • Korvick J, Yu VL. Simultaneous infection with Cryptococcus neoformans and Legionella pneumophila. In vivo expression of common defects in cell-mediated immunity. Respiration. 1988;53(2):132–136. [PubMed]
  • Korvick JA, Marsh JW, Starzl TE, Yu VL. Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery. 1991 Jan;109(1):62–68. [PMC free article] [PubMed]
  • Kovacs JA, Ng VL, Masur H, Leoung G, Hadley WK, Evans G, Lane HC, Ognibene FP, Shelhamer J, Parrillo JE, et al. Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med. 1988 Mar 10;318(10):589–593. [PubMed]
  • Kovarik J, Mayer G, Pohanka E, Schwarz M, Traindl O, Graf H, Smolen J. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation. 1988 Feb;45(2):402–405. [PubMed]
  • Kramer MR, Marshall SE, Denning DW, Keogh AM, Tucker RM, Galgiani JN, Lewiston NJ, Stevens DA, Theodore J. Cyclosporine and itraconazole interaction in heart and lung transplant recipients. Ann Intern Med. 1990 Aug 15;113(4):327–329. [PubMed]
  • Kramer MR, Denning DW, Marshall SE, Ross DJ, Berry G, Lewiston NJ, Stevens DA, Theodore J. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):552–556. [PubMed]
  • Kramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med. 1993 Sep 13;153(17):2010–2016. [PubMed]
  • Kramer MR, Stoehr C, Lewiston NJ, Starnes VA, Theodore J. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation--how effective and for how long? Transplantation. 1992 Mar;53(3):586–589. [PubMed]
  • Kramer P, ten Kate FW, Bijnen AB, Jeekel J, Weimar W. Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet. 1984 May 5;1(8384):989–990. [PubMed]
  • Kramer P, Prins ME, Kapsenberg JG, Bornkamm GW, Bijnen AB, Rohol PJ, van der Heul RO, Jeekel J, Weimar W. Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient. Cancer. 1985 Feb 1;55(3):503–509. [PubMed]
  • Krom RA, Kingma LM, Haagsma EB, Wesenhagen H, Slooff MJ, Gips CH. Choledochocholedochostomy, a relatively safe procedure in orthotopic liver transplantation. Surgery. 1985 May;97(5):552–556. [PubMed]
  • Kumar P, Pearson JE, Martin DH, Leech SH, Buisseret PD, Bezbak HC, Gonzalez FM, Royer JR, Streicher HZ, Saxinger WC. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Feb;106(2):244–245. [PubMed]
  • Kumar S, Trivedi HL, Smith EK. Letter: Rhinocerebral mucormycosis in a renal transplant patient. J Oral Surg. 1976 Jul;34(7):583–583. [PubMed]
  • Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, Tzakis AG, Starzl TE, Ho M. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988 Mar;67(2):132–143. [PMC free article] [PubMed]
  • Kusne S, Schwartz M, Breinig MK, Dummer JS, Lee RE, Selby R, Starzl TE, Simmons RL, Ho M. Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis. 1991 May;163(5):1001–1007. [PMC free article] [PubMed]
  • Kusne S, Tobin D, Pasculle AW, Van Thiel DH, Ho M, Starzl TE. Candida carriage in the alimentary tract of liver transplant candidates. Transplantation. 1994 Feb;57(3):398–402. [PMC free article] [PubMed]
  • Kusne S, Torre-Cisneros J, Mañez R, Irish W, Martin M, Fung J, Simmons RL, Starzl TE. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis. 1992 Dec;166(6):1379–1383. [PMC free article] [PubMed]
  • Laghi F, Yeldandi V, McCabe M, Garrity ER., Jr Common infections complicating lung transplantation. N J Med. 1993 Apr;90(4):317–319. [PubMed]
  • Lakshiminarayan S, Sahn SA. Tuberculosis in a patient after renal transplantation. Tubercle. 1973 Mar;54(1):72–76. [PubMed]
  • Lang P, Buisson C, Rostoker G, Ben Maadi A, Fruchaud G, Deforge L, Chopin D, Abbou C, Romano P, Fleury J, et al. DHPG treatment of kidney transplant recipients with severe CMV infection. Transplant Proc. 1989 Feb;21(1 Pt 2):2084–2086. [PubMed]
  • Langhoff E, Madsen S. Rapid metabolism of cyclosporin and prednisone in kidney transplant patients on tuberculostatic treatment. Lancet. 1983 Dec 3;2(8362):1303–1303. [PubMed]
  • Langlois RP, Flegel KM, Meakins JL, Morehouse DD, Robson HG, Guttmann RD. Cutaneous aspergillosis with fatal dissemination in a renal transplant recipient. Can Med Assoc J. 1980 Mar 22;122(6):673–676. [PMC free article] [PubMed]
  • Langnas AN, Markin RS, Cattral MS, Naides SJ. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology. 1995 Dec;22(6):1661–1665. [PubMed]
  • Laske A, Gallino A, Mohacsi P, Bauer EP, Carrel T, von Segesser LK, Turina MI. Prophylactic treatment with ganciclovir for cytomegalovirus infection in heart transplantation. Transplant Proc. 1991 Feb;23(1 Pt 2):1170–1173. [PubMed]
  • Lautenschlager I, Ahonen J, Eklund B, Höckerstedt K, Salmela K, Isoniemi H, Korsbäck C, Suni J, Häyry P. Hyperimmune globulin therapy of clinical CMV disease in renal allograft recipients. Transplant Proc. 1989 Feb;21(1 Pt 2):2087–2088. [PubMed]
  • Lazarovits AI, Tibbles LA, Grant DR, Ghent CN, Wall WJ, White MJ, Joncas JH. Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation. Clin Invest Med. 1994 Dec;17(6):621–625. [PubMed]
  • Leapman SB, Rosenberg JB, Filo RS, Smith EJ. Strongyloides stercoralis in chronic renal failure: safe therapy with thiabendazole. South Med J. 1980 Oct;73(10):1400–1402. [PubMed]
  • Lecatsas G. Papillomavirus in urine in pregnancy and following renal transplantation. Prog Clin Biol Res. 1983;105:143–148. [PubMed]
  • Le Conte P, Blanloeil Y, Michel P, Francois T, Paineau J. Cutaneous aspergillosis in a patient with orthotopic hepatic transplantation. Transplantation. 1992 May;53(5):1153–1154. [PubMed]
  • Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med. 1995 Jan 5;332(1):19–25. [PubMed]
  • Lee JY. Cytomegalovirus infection involving the skin in immunocompromised hosts. A clinicopathologic study. Am J Clin Pathol. 1989 Jul;92(1):96–100. [PubMed]
  • Leff RD, Smith EJ, Aldo-Benson MA, Aronoff GR. Cryptococcal arthritis after renal transplantation. South Med J. 1981 Oct;74(10):1290–1290. [PubMed]
  • Legendre C, Ducloux D, Ferroni A, Chkoff N, Valette C, Geffrier C, Rouzioux C, Kreis H. Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study. Transplant Proc. 1993 Feb;25(1 Pt 2):1431–1433. [PubMed]
  • Leiguarda R, Roncoroni A, Taratuto AL, Jost L, Berthier M, Nogues M, Freilij H. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology. 1990 May;40(5):850–851. [PubMed]
  • Le Saux NM, Sekla L, McLeod J, Parker S, Rush D, Jeffery JR, Brunham RC. Epidemic of nosocomial Legionnaires' disease in renal transplant recipients: a case-control and environmental study. CMAJ. 1989 May 1;140(9):1047–1053. [PMC free article] [PubMed]
  • Libow LF, Beltrani VP, Silvers DN, Grossman ME. Post-cardiac transplant reactivation of Chagas' disease diagnosed by skin biopsy. Cutis. 1991 Jul;48(1):37–40. [PubMed]
  • Lichtenstein IH, MacGregor RR. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis. 1983 Mar-Apr;5(2):216–226. [PubMed]
  • Linnemann CC, Jr, First MR, Schiffman G. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med. 1981 Nov;141(12):1637–1640. [PubMed]
  • Lipman MC, Pillay D, Squire SB, Sweny P, Johnson MA. HIV infection in a long-term renal transplant recipient. Int J STD AIDS. 1995 Mar-Apr;6(2):121–122. [PubMed]
  • Livas IC, Nechay PS, Nauseef WM. Clinical evidence of spinal and cerebral histoplasmosis twenty years after renal transplantation. Clin Infect Dis. 1995 Mar;20(3):692–695. [PubMed]
  • Lloveras J, Peterson PK, Simmons RL, Najarian JS. Mycobacterial infections in renal transplant recipients. Seven cases and a review of the literature. Arch Intern Med. 1982 May;142(5):888–892. [PubMed]
  • Locke TJ, Odom NJ, Tapson JS, Freeman R, McGregor CG. Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation. J Heart Transplant. 1987 Mar-Apr;6(2):120–122. [PubMed]
  • Lones MA, Mishalani S, Shintaku IP, Weiss LM, Nichols WS, Said JW. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. Hum Pathol. 1995 May;26(5):525–530. [PubMed]
  • Loria KM, Salinger MH, Frohlich TG, Gendelman MD, Cook FV, Arentzen CE. Primary cutaneous aspergillosis in a heart transplant recipient treated with surgical excision and oral itraconazole. J Heart Lung Transplant. 1992 Jan-Feb;11(1 Pt 1):156–159. [PubMed]
  • Luby JP, Ramirez-Ronda C, Rinner S, Hull A, Vergne-Marini P. A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis. 1977 Apr;135(4):659–663. [PubMed]
  • Lugo-Janer GJ, Pedraza R, Morales Otero LA, González ZA, Muñiz A, Sánchez J, Santiago-Delpín EA. Superficial mycosis in renal transplant recipients. Transplant Proc. 1991 Apr;23(2):1787–1788. [PubMed]
  • Lui SF, Ali AA, Grundy JE, Fernando ON, Griffiths PD, Sweny P. Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant. 1992;7(12):1230–1237. [PubMed]
  • Lumbreras C, Fernandez I, Velosa J, Munn S, Sterioff S, Paya CV. Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome. Clin Infect Dis. 1995 Mar;20(3):514–520. [PubMed]
  • Lumbreras C, Lizasoain M, Moreno E, Aguado JM, Gomez R, Garcia I, Gonzalez I, Loinaz C, Cisneros C, Noriega AR. Major bacterial infections following liver transplantation: a prospective study. Hepatogastroenterology. 1992 Aug;39(4):362–365. [PubMed]
  • Lumbreras C, Otero JR, Herrero JA, Gomez R, Lizasoain M, Aguado JM, Colina F, Garcia I, Moreno E, Noriega AR. Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies. Antimicrob Agents Chemother. 1993 Nov;37(11):2490–2492. [PMC free article] [PubMed]
  • Lynfield R, Herrin JT, Rubin RH. Varicella in pediatric renal transplant recipients. Pediatrics. 1992 Aug;90(2 Pt 1):216–220. [PubMed]
  • MacDonald AS, Belitsky P, Cohen A, Lee S. Cytomegalovirus disease prophylaxis in seronegative recipients of kidneys from seropositive donors by combination of cytomegalovirus-hyperimmune globulin and low-dose acyclovir. Transplant Proc. 1991 Feb;23(1 Pt 2):1355–1356. [PubMed]
  • Mai M, Nery J, Sutker W, Husberg B, Klintmalm G, Gonwa T. DHPG (Gancyclovir) improves survival in CMV pneumonia. Transplant Proc. 1989 Feb;21(1 Pt 2):2263–2265. [PubMed]
  • Maki DG, Fox BC, Kuntz J, Sollinger HW, Belzer FO. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine. J Lab Clin Med. 1992 Jan;119(1):11–24. [PubMed]
  • Mancini MC, McGinnis MR. Dactylaria infection of a human being: pulmonary disease in a heart transplant recipient. J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):827–830. [PubMed]
  • Maple PA, McKee T, Desselberger U, Wreghitt TG. Hepatitis C virus infections in transplant patients: serological and virological investigations. J Med Virol. 1994 Sep;44(1):43–48. [PubMed]
  • Marchevsky AM, Bottone EJ, Geller SA, Giger DK. The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Hum Pathol. 1980 Sep;11(5):457–464. [PubMed]
  • Marker SC, Simmons RL, Balfour HH., Jr Cytomegalovirus vaccine in renal allograft recipients. Transplant Proc. 1981 Mar;13(1 Pt 1):117–119. [PubMed]
  • Markin RS, Langnas AN, Donovan JP, Zetterman RK, Stratta RJ. Opportunistic viral hepatitis in liver transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1520–1521. [PubMed]
  • Martin M, Mañez R, Linden P, Estores D, Torre-Cisneros J, Kusne S, Ondick L, Ptachcinski R, Irish W, Kisor D, et al. A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation. 1994 Oct 15;58(7):779–785. [PMC free article] [PubMed]
  • Martin M, Kusne S, Alessiani M, Simmons R, Starzl TE. Infections after liver transplantation: risk factors and prevention. Transplant Proc. 1991 Jun;23(3):1929–1930. [PMC free article] [PubMed]
  • Martin-Santos JM, Alonso-Pulpon L, Pradas G, Cuervas-Mons V, Anguita M, Mulero-Mendoza J, Escribano E, Martinez-Beltran J, Figuera-Aymerich D. Septic arthritis by Salmonella enteritidis after heart transplantation. J Heart Transplant. 1987 May-Jun;6(3):177–179. [PubMed]
  • Martineau G, Porter KA, Corman J, Launois B, Schroter GT, Palmer W, Putnam CW, Groth CG, Halgrimson CG, Penn I, et al. Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery. 1972 Oct;72(4):604–610. [PMC free article] [PubMed]
  • Martinez AJ, Ahdab-Barmada M. The neuropathology of liver transplantation: comparison of main complications in children and adults. Mod Pathol. 1993 Jan;6(1):25–32. [PubMed]
  • Marzano A, Smedile A, Abate M, Ottobrelli A, Brunetto M, Negro F, Farci P, Durazzo M, David E, Lagget M, et al. Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence. J Hepatol. 1994 Dec;21(6):961–965. [PubMed]
  • Mauch TJ, Crouch NA, Freese DK, Braunlin EA, Dunn DL, Kashtan CE. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr. 1995 Dec;127(6):957–960. [PubMed]
  • Maurer JR, Snell G, deHoyos A, Kesten S, Winton T. Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens. Transplant Proc. 1993 Feb;25(1 Pt 2):1434–1435. [PubMed]
  • Maurer JR, Tullis DE, Grossman RF, Vellend H, Winton TL, Patterson GA. Infectious complications following isolated lung transplantation. Chest. 1992 Apr;101(4):1056–1059. [PubMed]
  • Mayer JM, Nimer L, Carroll K. Isolated pulmonary aspergillar infection in cardiac transplant recipients: case report and review. Clin Infect Dis. 1992 Oct;15(4):698–700. [PubMed]
  • Mayers DL, Martone WJ, Mandell GL. Cutaneous cryptococcosis mimicking gram-positive cellulitis in a renal transplant patient. South Med J. 1981 Aug;74(8):1032–1033. [PubMed]
  • McAllister WA, Thompson PJ, Al-Habet SM, Rogers HJ. Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 1983 Mar 19;286(6369):923–925. [PMC free article] [PubMed]
  • McCarthy JM, McLoughlin MG, Shackleton CR, Cameron EC, Yeung CK, Jones EC, Keown PA. Cytomegalovirus epididymitis following renal transplantation. J Urol. 1991 Aug;146(2):417–419. [PubMed]
  • McCaughan GW, McDonald JA, Davies S, Painter DM. Clinicopathological approach to human liver allograft dysfunction. J Gastroenterol Hepatol. 1989 Sep-Oct;4(5):467–477. [PubMed]
  • McCormick WF, Schochet SS, Jr, Sarles HE, Calverley JR. Progressive multifocal leukoencephalopathy in renal transplant recipients. Arch Intern Med. 1976 Jul;136(7):829–834. [PubMed]
  • McDougall JC, Vigneswaran WT, Peters SG, Marshall WT, McGregor CG. Fungal infection of the contralateral native lung after single-lung transplantation. Ann Thorac Surg. 1993 Jul;56(1):176–178. [PubMed]
  • McGregor CG, Daly RC, Peters SG, Midthun DE, Scott JP, Allen MS, Tazelaar HD, Keating MR, Walker RC, McDougall JC. Evolving strategies in lung transplantation for emphysema. Ann Thorac Surg. 1994 Jun;57(6):1513–1521. [PubMed]
  • McGregor RS, Zitelli BJ, Urbach AH, Malatack JJ, Gartner JC., Jr Varicella in pediatric orthotopic liver transplant recipients. Pediatrics. 1989 Feb;83(2):256–261. [PubMed]
  • McLeish KR, McMurray SD, Smith EJ, Filo RS. The transmission of Candida albicans by cadaveric allografts. J Urol. 1977 Oct;118(4):513–516. [PubMed]
  • McNeil MM, Brown JM, Magruder CH, Shearlock KT, Saul RA, Allred DP, Ajello L. Disseminated Nocardia transvalensis infection: an unusual opportunistic pathogen in severely immunocompromised patients. J Infect Dis. 1992 Jan;165(1):175–178. [PubMed]
  • Megison SM, Andrews WS. Combination therapy with ganciclovir and intravenous IgG for cytomegalovirus infections in pediatric liver transplant recipients. Transplantation. 1991 Jul;52(1):151–154. [PubMed]
  • Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med. 1992 Apr 30;326(18):1182–1186. [PubMed]
  • Metselaar HJ, Balk AH, Mochtar B, Rothbarth PH, Weimar W. Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulin. Chest. 1990 Feb;97(2):396–399. [PubMed]
  • Metselaar HJ, Rothbarth PH, Brouwer RM, Wenting GJ, Jeekel J, Weimar W. Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection. Transplantation. 1989 Aug;48(2):264–266. [PubMed]
  • Mezo A, Jennis F, McCarthy SW, Dawson DJ. Unusual mycobacteria in 5 cases of opportunistic infections. Pathology. 1979 Jul;11(3):377–384. [PubMed]
  • Michaels MG, Wald ER, Fricker FJ, del Nido PJ, Armitage J. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis. 1992 Apr;14(4):847–851. [PubMed]
  • Milbradt H, Flik J, Stangel W, Heigel R. Bedeutung der Untersuchung auf Antikörper gegen Cytomegalievirus bei Organtransplantationen. Beitr Infusionsther. 1990;26:33–36. [PubMed]
  • Hirsch MS, Schooley RT. Resistance to antiviral drugs: the end of innocence. N Engl J Med. 1989 Feb 2;320(5):313–314. [PubMed]
  • Mirza SH. Disseminated Trichosporon beigelii infection causing skin lesions in a renal transplant patient. J Infect. 1993 Jul;27(1):67–70. [PubMed]
  • Mishima T, Kobayashi Y, Ohkubo M, Marumo F, Yoshimura H. A case of renal transplant recipient complicated with cryptococcosis and amphotericin B induced acute tubular necrosis. Jpn Circ J. 1977 Sep;41(9):1009–1013. [PubMed]
  • Mocelin AJ, Brandina L, Gordan PA, Baldy JL, Chieffi PP. Immunosuppression and circulating Trypanosoma cruzi in a kidney transplant recipient. Transplantation. 1977 Feb;23(2):163–163. [PubMed]
  • Modry DL, Stinson EB, Oyer PE, Jamieson SW, Baldwin JC, Shumway NE. Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin. Transplantation. 1985 Mar;39(3):313–314. [PubMed]
  • Mollison LC, Richards MJ, Johnson PD, Hayes K, Munckhof WJ, Jones RM, Dabkowski PD, Angus PW. High-dose oral acyclovir reduces the incidence of cytomegalovirus infection in liver transplant recipients. J Infect Dis. 1993 Sep;168(3):721–724. [PubMed]
  • Monteforte JS, Wood CA. Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation. Eur J Clin Microbiol Infect Dis. 1993 Feb;12(2):112–114. [PubMed]
  • Mora NP, Cofer JB, Solomon H, Goldstein RM, Gonwa TA, Husberg BS, Klintmalm GB. Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc. 1991 Feb;23(1 Pt 2):1528–1530. [PubMed]
  • Mora NP, Klintmalm G, Solomon H, Goldstein RM, Gonwa TA, Husberg BS. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc. 1992 Feb;24(1):154–155. [PubMed]
  • Morales LA, González ZA, Santiago-Delpín EA. Chromoblastomycosis in a renal transplant patient. Nephron. 1985;40(2):238–240. [PubMed]
  • Morduchowicz G, Pitlik SD, Shapira Z, Shmueli D, Yussim A, Djalovski S, Rosenfeld JB. Infections in renal transplant recipients in Israel. Isr J Med Sci. 1985 Oct;21(10):791–797. [PubMed]
  • Morgan JS, Schaffner W, Stone WJ. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation. 1986 Nov;42(5):518–524. [PubMed]
  • Mourad G, Soulillou JP, Chong G, Pouliquen M, Hourmant M, Mion C. Transmission of Mycobacterium tuberculosis with renal allografts. Nephron. 1985;41(1):82–85. [PubMed]
  • Moulsdale M, Harper JM, Thatcher GN. Unusual mycobacterium infection in a renal transplant recipient. Med J Aust. 1980 Oct 18;2(8):450–451. [PubMed]
  • Mulligan DC, Goldstein RM, Crippin JS, Abouljoud MS, Levy MF, Husberg BS, Gonwa TA, Foster BR, Tillery GW, Klintmalm GB. Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplant Proc. 1995 Feb;27(1):1204–1205. [PubMed]
  • Murdoch ME, Leigh IM. Sporotrichoid spread of cutaneous Mycobacterium chelonei infection. Clin Exp Dermatol. 1989 Jul;14(4):309–312. [PubMed]
  • Murray HW, Moore JO, Luff RD. Disseminated aspergillosis in a renal transplant patient: Diagnostic difficulties re-emphasized. Johns Hopkins Med J. 1975 Nov;137(5):235–237. [PubMed]
  • Murray-Leisure KA, Aber RC, Rowley LJ, Applebaum PC, Wisman CB, Pennock JL, Pierce WS. Disseminated Trichosporon beigelii (cutaneum) infection in an artificial heart recipient. JAMA. 1986 Dec 5;256(21):2995–2998. [PubMed]
  • Nadasdy T, Park CS, Peiper SC, Wenzl JE, Oates J, Silva FG. Epstein-Barr virus infection-associated renal disease: diagnostic use of molecular hybridization technology in patients with negative serology. J Am Soc Nephrol. 1992 Jun;2(12):1734–1742. [PubMed]
  • Naidoff MA, Green WR. Endogenous Aspergillus endophthalmitis occurring after kidney transplant. Am J Ophthalmol. 1975 Mar;79(3):502–509. [PubMed]
  • Nakazato PZ, Burns W, Moore P, Garcia-Kennedy R, Cox K, Esquivel C. Viral prophylaxis in hepatic transplantation: preliminary report of a randomized trial of acyclovir and gancyclovir. Transplant Proc. 1993 Apr;25(2):1935–1937. [PubMed]
  • Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988 Oct;133(1):173–192. [PubMed]
  • Natås OB, Willassen Y. Lung infection caused by Nocardia asteroides in a renal-transplant patient. Scand J Infect Dis. 1983;15(3):317–320. [PubMed]
  • Nathan SD, Ross DJ, Zakowski P, Kass RM, Koerner SK. Utility of inhaled pentamidine prophylaxis in lung transplant recipients. Chest. 1994 Feb;105(2):417–420. [PubMed]
  • Neeley SP, Denning DW. Cutaneous Mycobacterium thermoresistibile infection in a heart transplant recipient. Rev Infect Dis. 1989 Jul-Aug;11(4):608–611. [PubMed]
  • Nemec DK, Lederer ED, Samo T. Candidal splenic abscess in a renal transplant patient. Am J Kidney Dis. 1989 Nov;14(5):408–411. [PubMed]
  • Ness MJ, Markin RS, Wood RP, Shaw BW, Jr, Woods GL. Disseminated Trichosporon beigelii infection after orthotopic liver transplantation. Am J Clin Pathol. 1989 Jul;92(1):119–123. [PubMed]
  • Nicol DL, MacDonald AS, Belitsky P, Lee S, Cohen AD, Bitter-Suermann H, Lowen J, Whalen A. Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipients. Transplantation. 1993 Apr;55(4):841–846. [PubMed]
  • Nicholson ML, Veitch PS, Donnelly PK, Bell PR. Systemic candidiasis caused by a renal transplant ureteric stent. Br J Urol. 1992 Oct;70(4):448–449. [PubMed]
  • Nicholson ML, Veitch PS, Donnelly PK, Flower AJ, Bell PR. Treatment of renal transplant-associated cytomegalovirus infection with ganciclovir. Transplant Proc. 1990 Aug;22(4):1811–1812. [PubMed]
  • Niklasson PM, Hambraeus A, Lundgren G, Magnusson G, Sundelin P, Groth CG. Listeria encephalitis in five renal transplant recipients. Acta Med Scand. 1978;203(3):181–185. [PubMed]
  • Nordén G, Björck S, Persson H, Svalander C, Li XG, Edebo L. Cure of zygomycosis caused by a lipase-producing Rhizopus rhizopodiformis strain in a renal transplant patient. Scand J Infect Dis. 1991;23(3):377–382. [PubMed]
  • Novick RJ, Moreno-Cabral CE, Stinson EB, Oyer PE, Starnes VA, Hunt SA, Shumway NE. Nontuberculous mycobacterial infections in heart transplant recipients: a seventeen-year experience. J Heart Transplant. 1990 Jul-Aug;9(4):357–363. [PubMed]
  • Oaks TE, Pae WE, Pennock JL, Myers JL, Pierce WS. Aortic rupture caused by fungal aortitis: successful management after heart transplantation. J Heart Transplant. 1988 Mar-Apr;7(2):162–164. [PubMed]
  • Offermann G, Keller F, Molzahn M. Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment. Am J Nephrol. 1985;5(5):385–387. [PubMed]
  • O'Grady JG, Alexander GJ, Sutherland S, Donaldson PT, Harvey F, Portmann B, Calne RY, Williams R. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet. 1988 Aug 6;2(8606):302–305. [PubMed]
  • Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F, Rogers K. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg. 1994 Mar;81(3):365–367. [PubMed]
  • O'Hair DP, Johnson CP, Roza AM, Adams MB. Treatment of transplant rejection in the presence of cytomegalovirus viremia. Transplant Proc. 1990 Aug;22(4):1815–1817. [PubMed]
  • Oliver WA. Tuberculosis in renal transplant patients. Med J Aust. 1976 May 29;1(22):828–829. [PubMed]
  • Orr KE, Gould FK, Short G, Dark JH, Hilton CJ, Corris PA, Freeman R. Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J Infect. 1994 Nov;29(3):249–253. [PubMed]
  • Owens NJ, Nightingale CH, Schweizer RT, Schauer PK, Dekker PT, Quintiliani R. Prophylaxis of oral candidiasis with clotrimazole troches. Arch Intern Med. 1984 Feb;144(2):290–293. [PubMed]
  • Palazzo JP, Lundquist K, Mitchell D, Mittal KR, Hann HW, Munoz S, Moritz MJ, Jacobs JM, Martin P. Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis. Am J Gastroenterol. 1993 Jan;88(1):102–104. [PubMed]
  • Palestine AG. Clinical aspects of cytomegalovirus retinitis. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S515–S521. [PubMed]
  • Palmer BF, Hernandez J, Sagalowsky A, Dawidson I, Helderman JH. Documentation of fungal pyelonephritis of the renal allograft by fine needle aspiration cytology. Transplant Proc. 1989 Aug;21(4):3598–3599. [PubMed]
  • Pan SH, Rosenthal P, Howard TK, Podesta LG, Sher L, Makowka L. Evaluation of three cytomegalovirus infection prophylactic regimens in liver transplant recipients. Transplant Proc. 1992 Aug;24(4):1466–1467. [PubMed]
  • Paradis IL, Williams P. Infection after lung transplantation. Semin Respir Infect. 1993 Sep;8(3):207–215. [PubMed]
  • Pass RF, Long WK, Whitley RJ, Soong SJ, Diethelm AG, Reynolds DW, Alford CA., Jr Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source of kidney. J Infect Dis. 1978 May;137(5):556–563. [PubMed]
  • Pass RF, Whitley RJ, Whelchel JD, Diethelm AG, Reynolds DW, Alford CA. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis. 1979 Oct;140(4):487–492. [PubMed]
  • Patel R, Cockerill FR, Porayko MK, Osmon DR, Ilstrup DM, Keating MR. Lactobacillemia in liver transplant patients. Clin Infect Dis. 1994 Feb;18(2):207–212. [PubMed]
  • Patel R, Gustaferro CA, Krom RA, Wiesner RH, Roberts GD, Paya CV. Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient. Clin Infect Dis. 1994 Jul;19(1):198–200. [PubMed]
  • Patel R, Klein DW, Espy MJ, Harmsen WS, Ilstrup DM, Paya CV, Smith TF. Optimization of detection of cytomegalovirus viremia in transplantation recipients by shell vial assay. J Clin Microbiol. 1995 Nov;33(11):2984–2986. [PMC free article] [PubMed]
  • Patel R, Roberts GD, Keating MR, Paya CV. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis. 1994 Aug;19(2):263–273. [PubMed]
  • Patel R, Smith TF, Espy M, Portela D, Wiesner RH, Krom RA, Paya CV. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis. 1995 Apr;171(4):1010–1014. [PubMed]
  • Patel R, Smith TF, Espy M, Wiesner RH, Krom RA, Portela D, Paya CV. Detection of cytomegalovirus DNA in sera of liver transplant recipients. J Clin Microbiol. 1994 Jun;32(6):1431–1434. [PMC free article] [PubMed]
  • Patel SR, Kirby TJ, McCarthy PM, Meeker DP, Stillwell P, Rice TW, Kavuru MS, Mehta AC. Lung transplantation: the Cleveland Clinic experience. Cleve Clin J Med. 1993 Jul-Aug;60(4):303–319. [PubMed]
  • Patterson JW, Broecker AH, Kornstein MJ, Mills AS. Cutaneous cytomegalovirus infection in a liver transplant patient. Diagnosis by in situ DNA hybridization. Am J Dermatopathol. 1988 Dec;10(6):524–530. [PubMed]
  • Patterson TF, Andriole VT, Zervos MJ, Therasse D, Kauffman CA. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses. 1990 Jun;33(6):297–302. [PubMed]
  • Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis. 1993 May;16(5):677–688. [PubMed]
  • Paya CV, Hermans PE. Bacterial infections after liver transplantation. Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):499–504. [PubMed]
  • Paya CV, Hermans PE, Washington JA, 2nd, Smith TF, Anhalt JP, Wiesner RH, Krom RA. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc. 1989 May;64(5):555–564. [PubMed]
  • Paya CV, Hermans PE, Smith TF, Rakela J, Wiesner RH, Krom RA, Torres VE, Sterioff S, Wilkowske CJ. Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation. 1988 Aug;46(2):229–234. [PubMed]
  • Paya CV, Hermans PE, Wiesner RH, Ludwig J, Smith TF, Rakela J, Krom RA. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis. 1989 Nov;160(5):752–758. [PubMed]
  • Paya CV, Marin E, Keating M, Dickson R, Porayko M, Wiesner R. Solid organ transplantation: results and implications of acyclovir use in liver transplants. J Med Virol. 1993;Suppl 1:123–127. [PubMed]
  • Paya CV, Smith TF, Ludwig J, Hermans PE. Rapid shell vial culture and tissue histology compared with serology for the rapid diagnosis of cytomegalovirus infection in liver transplantation. Mayo Clin Proc. 1989 Jun;64(6):670–675. [PubMed]
  • Paya CV, Wiesner RH, Hermans PE, Larson-Keller JJ, Ilstrup DM, Krom RA, Rettke S, Smith TF. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol. 1993 Jun;18(2):185–195. [PubMed]
  • Paya CV, Wiesner RH, Hermans PE, Larson-Keller JJ, Ilstrup DM, Krom RA, Moore SB, Ludwig J, Smith TF. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. Hepatology. 1992 Jul;16(1):66–70. [PubMed]
  • Pehlivanoğlu E, Ament ME, Spolidoro JV, Vargas J, Busuttil R, Berquist WE. Severe cytomegalovirus infection and immunosuppressive therapy in pediatric liver transplantation. Turk J Pediatr. 1990 Jan-Mar;32(1):3–11. [PubMed]
  • Perandones CE, Roncoroni AJ, Frega NS, Bianchini HM, Hübscher O. Mycobacterium gastri arthritis: septic arthritis due to Mycobacterium gastri in a patient with a renal transplant. J Rheumatol. 1991 May;18(5):777–778. [PubMed]
  • Pereira BJ. Hepatitis C in organ transplantation: its significance and influence on transplantation policies. Curr Opin Nephrol Hypertens. 1993 Nov;2(6):912–922. [PubMed]
  • Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med. 1991 Aug 15;325(7):454–460. [PubMed]
  • Perfect JR, Durack DT, Gallis HA. Cryptococcemia. Medicine (Baltimore) 1983 Mar;62(2):98–109. [PubMed]
  • Perschak H, Gubler J, Speich R, Russi E. Pulmonary nocardiosis concurrent with Pneumocystis carinii pneumonia in two patients undergoing immunosuppressive therapy. J Infect. 1991 Sep;23(2):183–185. [PubMed]
  • Peters C, Peterson P, Marabella P, Simmons RL, Najarian JS. Continuous sulfa prophylaxis for urinary tract infection in renal transplant recipients. Am J Surg. 1983 Nov;146(5):589–593. [PubMed]
  • Peterson PK, Dahl MV, Howard RJ, Simmons RL, Najarian JS. Mucormycosis and cutaneous histoplasmosis in a renal transplant recipient. Arch Dermatol. 1982 Apr;118(4):275–277. [PubMed]
  • Pettersson E, Hovi T, Ahonen J, Fiddian AP, Salmela K, Höckerstedt K, Eklund B, von Willebrand E, Häyry P. Prophylactic oral acyclovir after renal transplantation. Transplantation. 1985 Mar;39(3):279–281. [PubMed]
  • Pirsch JD, Armbrust MJ, Stratta RJ, D'Alessandro AM, Sollinger HW, Belzer FO, Kalayoglu M, Maki DG. Perioperative infection in liver transplant recipients under a quadruple immunosuppressive protocol. Transplant Proc. 1989 Jun;21(3):3559–3559. [PubMed]
  • Plá MP, Berenguer J, Arzuaga JA, Bañares R, Polo JR, Bouza E. Surgical wound infection by Aspergillus fumigatus in liver transplant recipients. Diagn Microbiol Infect Dis. 1992 Nov-Dec;15(8):703–706. [PubMed]
  • Plotkin SA, Smiley ML, Friedman HM, Starr SE, Fleisher GR, Wlodaver C, Dafoe DC, Friedman AD, Grossman RA, Barker CF. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet. 1984 Mar 10;1(8376):528–530. [PubMed]
  • Plotkin SA, Huang ES. Cytomegalovirus vaccine virus (Towne strain) does not induce latency. J Infect Dis. 1985 Aug;152(2):395–397. [PubMed]
  • Plotkin SA, Starr SE, Friedman HM, Brayman K, Harris S, Jackson S, Tustin NB, Grossman R, Dafoe D, Barker C. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med. 1991 Apr 1;114(7):525–531. [PubMed]
  • Pluemecke G, Williams J, Elliott D, Paul LC. Renal transplant artery rupture secondary to candida infection. Nephron. 1992;61(1):98–101. [PubMed]
  • Polo JM, Fábrega E, Casafont F, Fariñas MC, Salesa R, Vázquez A, Berciano J. Treatment of cerebral aspergillosis after liver transplantation. Neurology. 1992 Sep;42(9):1817–1819. [PubMed]
  • Portela D, Patel R, Larson-Keller JJ, Ilstrup DM, Wiesner RH, Steers JL, Krom RA, Paya CV. OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. J Infect Dis. 1995 Apr;171(4):1014–1018. [PubMed]
  • Power C, Poland SD, Kassim KH, Kaufmann JC, Rice GP. Encephalopathy in liver transplantation: neuropathology and CMV infection. Can J Neurol Sci. 1990 Nov;17(4):378–381. [PubMed]
  • Prayson RA, Estes ML. The neuropathology of cardiac allograft transplantation. An autopsy series of 18 patients. Arch Pathol Lab Med. 1995 Jan;119(1):59–63. [PubMed]
  • Preiksaitis JK, Diaz-Mitoma F, Mirzayans F, Roberts S, Tyrrell DL. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J Infect Dis. 1992 Nov;166(5):986–994. [PubMed]
  • Prian GW, Koep LJ. Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir. Transplant Proc. 1994 Oct;26(5 Suppl 1):54–55. [PubMed]
  • Proca E, Popescu A. Tuberculous cerebral abscess 8 years after renal transplantation. Br J Urol. 1991 Aug;68(2):205–205. [PubMed]
  • Prodinger WM, Bonatti H, Allerberger F, Wewalka G, Harrison TG, Aichberger C, Dierich MP, Margreiter R, Tiefenbrunner F. Legionella pneumonia in transplant recipients: a cluster of cases of eight years' duration. J Hosp Infect. 1994 Mar;26(3):191–202. [PubMed]
  • Prokurat S, Drabik E, Grenda R, Vogt E. Ganciclovir in cytomegalovirus prophylaxis in high-risk pediatric renal transplant recipients. Transplant Proc. 1993 Aug;25(4):2577–2577. [PubMed]
  • Qadri SM, Al Dayel F, Strampfer MJ, Cunha BA. Urinary tract infection caused by Hansenula anomala. Mycopathologia. 1988 Nov;104(2):99–101. [PubMed]
  • Qunibi WY, al-Sibai MB, Taher S, Harder EJ, de Vol E, al-Furayh O, Ginn HE. Mycobacterial infection after renal transplantation--report of 14 cases and review of the literature. Q J Med. 1990 Oct;77(282):1039–1060. [PubMed]
  • Raakow R, Steffen R, Lefèbre B, Bechstein WO, Blumhardt G, Neuhaus P. Selective bowel decontamination effectively prevents gram-negative bacterial infections after liver transplantation. Transplant Proc. 1990 Aug;22(4):1556–1557. [PubMed]
  • Raby N, Forbes G, Williams R. Nocardia infection in patients with liver transplants or chronic liver disease: radiologic findings. Radiology. 1990 Mar;174(3 Pt 1):713–716. [PubMed]
  • Rakela J, Wiesner RH, Taswell HF, Hermans PE, Smith TF, Perkins JD, Krom RA. Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. Transplant Proc. 1987 Feb;19(1 Pt 3):2399–2402. [PubMed]
  • Ralph ED, Barber KR, Grant CW. Liposomal amphotericin B: an effective, nontoxic preparation for the treatment of urinary tract infections caused by Candida albicans. Am J Nephrol. 1991;11(2):118–122. [PubMed]
  • Ramirez JC, Patterson GA, Winton TL, de Hoyos AL, Miller JD, Maurer JR. Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg. 1992 Feb;103(2):287–294. [PubMed]
  • Ramon Y, Oberman M, Horowitz I, Freedman A. Extensive maxillary sequestration resulting from rhinocerebral mucormyocosis. J Oral Surg. 1977 Dec;35(12):989–991. [PubMed]
  • Rancewicz Z, Halama G, Smogorzewski M, Durlik M, Rowinska D, Lao M, Juskowa J, Wyzgal J. The usefulness of hyperimmune globulin for treatment of overt cytomegalovirus infection in allograft recipients. Transplant Proc. 1990 Aug;22(4):1818–1819. [PubMed]
  • Randhawa PS, Yousem SA. Epstein-Barr virus-associated lymphoproliferative disease in a heart-lung allograft. Demonstration of host origin by restriction fragment-length polymorphism analysis. Transplantation. 1990 Jan;49(1):126–130. [PubMed]
  • Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol. 1989 Aug;92(2):177–185. [PubMed]
  • Rao KV, O'Brien TJ, Andersen RC. Septic arthritis due to Nocardia asteroides after successful kidney transplantation. Arthritis Rheum. 1981 Jan;24(1):99–101. [PubMed]
  • Rappaport DC, Weisbrod GL, Herman SJ. Cyclosporine-induced lymphoma following a unilateral lung transplant. The Toronto Lung Transplant Group. Can Assoc Radiol J. 1989 Apr;40(2):110–111. [PubMed]
  • Rattazzi LC, Simmons RL, Spanos PK, Bradford DS, Najarian JS. Successful management of miliary tuberculosis after renal transplantation. Am J Surg. 1975 Sep;130(3):359–361. [PubMed]
  • Reed EC, Wolford JL, Kopecky KJ, Lilleby KE, Dandliker PS, Todaro JL, McDonald GB, Meyers JD. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. Ann Intern Med. 1990 Apr 1;112(7):505–510. [PubMed]
  • Rees W, Schüler S, Hummel M, Hempel S, Möller J, Hetzer R. Primary cutaneous Nocardia farcinica infection after heart transplantation: a case report. J Thorac Cardiovasc Surg. 1995 Jan;109(1):181–183. [PubMed]
  • Rela M, Heaton ND, Vougas V, Rolando N, Wade J, Portmann B, Williams R, Tan KC. Gangrene of the anterior abdominal wall after orthotopic liver transplantation: invasive cutaneous candidiasis. Postgrad Med J. 1993 Jun;69(812):494–496. [PMC free article] [PubMed]
  • Renoult E, Aymard B, Grégoire MJ, Bellou A, Hubert J, Hestin D, Audouin J, Lederlin P, Kessler M. Epstein-Barr virus lymphoproliferative disease of donor origin after kidney transplantation: a case report. Am J Kidney Dis. 1995 Jul;26(1):84–87. [PubMed]
  • Renoult E, Kessler M, Jonon B, Schmit JL. Significance of seroconversion against Legionella after renal transplantation: report of five cases. Clin Nephrol. 1990 Apr;33(4):209–209. [PubMed]
  • Reyes J, Abu-Elmagd K, Tzakis A, Nour B, Casavilla A, Kusne S, Green M, Alessiani M, Jain A, Fung JJ, et al. Infectious complications after human small bowel transplantation. Transplant Proc. 1992 Jun;24(3):1249–1250. [PMC free article] [PubMed]
  • Reznik M, Halleux J, Urbain E, Mouchette R, Castermans P, Beaujean M. Two cases of progressive multifocal leukoencephalopathy after renal transplantation. Acta Neuropathol Suppl. 1981;7:189–191. [PubMed]
  • Ribot S, Eslami HH. HIV infection in kidney transplant recipients. N J Med. 1992 Aug;89(8):597–599. [PubMed]
  • Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McCluskey RT, Russell PS, et al. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med. 1981 Jul 9;305(2):57–63. [PubMed]
  • Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 1994 Aug 1;84(3):972–984. [PubMed]
  • Rifkind D, Marchioro TL, Schneck SA, Hill RB., Jr Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med. 1967 Jul;43(1):28–38. [PubMed]
  • Ringdén O, Lönnqvist B, Paulin T, Ahlmén J, Klintmalm G, Wahren B, Lernestedt JO. Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. J Antimicrob Chemother. 1986 Mar;17(3):373–387. [PubMed]
  • Riska H, Kuhlbäck B. Tuberculosis and kidney transplantation. Acta Med Scand. 1979;205(7):637–640. [PubMed]
  • Rondeau E, Bourgeon B, Peraldi MN, Lang P, Buisson C, Schulte KM, Weill B, Sraer JD. Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant. 1993;8(9):858–862. [PubMed]
  • Rondeau E, Farquet C, Ruedin P, Fries D, Sraer JD. Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients. Transplant Proc. 1990 Aug;22(4):1813–1814. [PubMed]
  • Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S460–S467. [PubMed]
  • Rosen T. Cutaneous Mycobacterium kansasii infection presenting as cellulitis. Cutis. 1983 Jan;31(1):87–89. [PubMed]
  • Rosman C, Klompmaker IJ, Bonsel GJ, Bleichrodt RP, Arends JP, Slooff MJ. The efficacy of selective bowel decontamination as infection prevention after liver transplantation. Transplant Proc. 1990 Aug;22(4):1554–1555. [PubMed]
  • Ross CN, Beynon HL, Savill JS, Watkins RP, Cohen J, Pusey CD, Rees AJ. Ganciclovir treatment for cytomegalovirus infection in immunocompromised patients with renal disease. Q J Med. 1991 Nov;81(295):929–936. [PubMed]
  • Rossaint R, Raakow R, Lewandowski K, Slama K, Steffen R, Blumhardt G, Lütgebrune R, Neuhaus P, Falke K. Strategy for prevention of infection after orthotopic liver transplantation. Transplant Proc. 1991 Jun;23(3):1965–1966. [PubMed]
  • Roth D, Zucker K, Cirocco R, DeMattos A, Burke GW, Nery J, Esquenazi V, Babischkin S, Miller J. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int. 1994 Jan;45(1):238–244. [PubMed]
  • Rubin RH. Infectious disease complications of renal transplantation. Kidney Int. 1993 Jul;44(1):221–236. [PubMed]
  • Rubin RH, Tolkoff-Rubin NE. Antimicrobial strategies in the care of organ transplant recipients. Antimicrob Agents Chemother. 1993 Apr;37(4):619–624. [PMC free article] [PubMed]
  • Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE. Infection in the renal transplant recipient. Am J Med. 1981 Feb;70(2):405–411. [PubMed]
  • Ruskin JD, Wood RP, Bailey MR, Whitmore CK, Shaw BW. Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients. Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):567–571. [PubMed]
  • Ryan CG, Dwyer BW. New characteristics of Mycobacterium haemophilum. J Clin Microbiol. 1983 Oct;18(4):976–977. [PMC free article] [PubMed]
  • Sack K, Schwieder G, Marre R, Hoyer J. Nocardial infection in a renal transplant recipient--a case report. Scand J Urol Nephrol Suppl. 1985;92:59–66. [PubMed]
  • Saigenji H, Kaneko M, Rhenmen B, Williams RJ, Vasu MA, Icenogle TB, Copeland JG. Pneumocystis carinii pneumonia after heart transplantation. Ann Thorac Surg. 1991 Jul;52(1):107–111. [PubMed]
  • Saliba F, Arulnaden JL, Gugenheim J, Serves C, Samuel D, Bismuth A, Mathieu D, Bismuth H. CMV hyperimmune globulin prophylaxis after liver transplantation: a prospective randomized controlled study. Transplant Proc. 1989 Feb;21(1 Pt 2):2260–2262. [PubMed]
  • Saliba F, Eyraud D, Samuel D, David MF, Arulnaden JL, Dussaix E, Mathieu D, Bismuth H. Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients. Transplant Proc. 1993 Feb;25(1 Pt 2):1444–1445. [PubMed]
  • Saliba F, Gugenheim J, Samuel D, Bismuth A, Mathieu D, Serres C, Bismuth H. Incidence of cytomegalovirus infection and effects of cytomegalovirus immune globulin prophylaxis after orthotopic liver transplantation. Transplant Proc. 1987 Oct;19(5):4081–4082. [PubMed]
  • Salizzoni JL, Tiruviluamala P, Reichman LB. Liver transplantation: an unheralded probable risk for tuberculosis. Tuber Lung Dis. 1992 Aug;73(4):232–238. [PubMed]
  • Salmela K, Höckerstedt K, Lautenschlager I, Eklund B, Isoniemi H, Holmberg C, Ahonen J. Ganciclovir in the treatment of severe cytomegalovirus disease in liver transplant patients. Transplant Proc. 1990 Feb;22(1):238–240. [PubMed]
  • Salt A, Sutehall G, Sargaison M, Woodward C, Barnes ND, Calne RY, Wreghitt TG. Viral and toxoplasma gondii infections in children after liver transplantation. J Clin Pathol. 1990 Jan;43(1):63–67. [PMC free article] [PubMed]
  • Sampaio M, Ianhez LE, Sabbaga E. Protective effect of cyclosporine in human renal posttransplant cryptococcosis. Transplant Proc. 1992 Dec;24(6):3091–3091. [PubMed]
  • Samra Y, Shaked Y, Maier MK. Nontyphoid salmonellosis in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis. 1986 May-Jun;8(3):431–440. [PubMed]
  • Samuel D, Bismuth A, Serres C, Arulnaden JL, Reynes M, Benhamou JP, Brechot C, Bismuth H. HBV infection after liver transplantation in HBsAg positive patients: experience with long-term immunoprophylaxis. Transplant Proc. 1991 Feb;23(1 Pt 2):1492–1494. [PubMed]
  • Sanger JR, Stampfl DA, Franson TR. Recurrent granulomatous synovitis due to Mycobacterium kansasii in a renal transplant recipient. J Hand Surg Am. 1987 May;12(3):436–441. [PubMed]
  • Santiago-Delpín EA, Mora E, González ZA, Morales-Otero LA, Bermudez R. Factors in an outbreak of Pneumocystis carinii in a transplant unit. Transplant Proc. 1988 Feb;20(1 Suppl 1):462–465. [PubMed]
  • Sartin JS, Wilhelm MP, Keating MR, Batts K, Krom RA. A case of Aspergillus fumigatus peritonitis complicating liver transplantation. Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):25–28. [PubMed]
  • Sawyer MD, Mayoral JL, Gillingham KJ, Kramer MA, Dunn DL. Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants. Arch Surg. 1993 Feb;128(2):165–170. [PubMed]
  • Sayage LH, Gonwa TA, Goldstein RM, Husberg BS, Klintmalm GB. Cytomegalovirus infection in orthotopic liver transplantation. Transpl Int. 1989 Aug;2(2):96–101. [PubMed]
  • Sayers MH, Anderson KC, Goodnough LT, Kurtz SR, Lane TA, Pisciotto P, Silberstein LE. Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann Intern Med. 1992 Jan 1;116(1):55–62. [PubMed]
  • Schad GA. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis. 1986 Jan;153(1):178–178. [PubMed]
  • Schäfers HJ, Cremer J, Wahlers T, Holle W, Fieguth HG, Herrmann G, Haverich A. Pneumocystis carinii pneumonia following heart transplantation. Eur J Cardiothorac Surg. 1987;1(1):49–52. [PubMed]
  • Schmidt K, Burdelski M, Bernsau U, Brodehl J, Ringe B, Lauchart W, Wonigeit K, Pichlmayr R, Milbradt H. Analysis of current results of liver transplantation in children. Transplant Proc. 1987 Feb;19(1 Pt 3):2449–2450. [PubMed]
  • Schober R, Herman MM. Neuropathology of cardiac transplantation. Survey of 31 cases. Lancet. 1973 May 5;1(7810):962–967. [PubMed]
  • Schröter GP, Weil R., 3rd Listeria monocytogenes infection after renal transplantation. Arch Intern Med. 1977 Oct;137(10):1395–1399. [PubMed]
  • Schröter GP, Bakshandeh K, Husberg BS, Well R., 3rd Coccidioidomycosis and renal transplantation. Transplantation. 1977 Jun;23(6):485–489. [PubMed]
  • Schröter GP, Hoelscher M, Putnam CW, Porter KA, Starzl TE. Fungus infections after liver transplantation. Ann Surg. 1977 Jul;186(1):115–122. [PubMed]
  • Schröter GP, Hoelscher M, Putnam CW, Porter KA, Hansbrough JF, Starzl TE. Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg. 1976 Dec;111(12):1337–1347. [PMC free article] [PubMed]
  • Schröter GP, Temple DR, Husberg BS, Weil R, 3rd, Starzl TE. Cryptococcosis after renal transplantation: report of ten cases. Surgery. 1976 Mar;79(3):268–277. [PMC free article] [PubMed]
  • Schumaker JD, Band JD, Lensmeyer GL, Craig WA. Thiabendazole treatment of severe strongyloidiasis in a hemodialyzed patient. Ann Intern Med. 1978 Nov;89(5 Pt 1):644–645. [PubMed]
  • Schwarz A, Hoffmann F, L'age-Stehr J, Tegzess AM, Offermann G. Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients. Transplantation. 1987 Jul;44(1):21–24. [PubMed]
  • Schwend M, Tiemann M, Kreipe HH, Parwaresch MR, Kraatz EG, Herrmann G, Spielmann RP, Barth J. Rapidly growing Epstein-Barr virus-associated pulmonary lymphoma after heart transplantation. Eur Respir J. 1994 Mar;7(3):612–616. [PubMed]
  • Scoggin CH, Call NB. Acute respiratory failure due to disseminated strongyloidiasis in a renal transplant recipient. Ann Intern Med. 1977 Oct;87(4):456–458. [PubMed]
  • Scroggs MW, Wolfe JA, Bollinger RR, Sanfilippo F. Causes of death in renal transplant recipients. A review of autopsy findings from 1966 through 1985. Arch Pathol Lab Med. 1987 Oct;111(10):983–987. [PubMed]
  • Seale L, Jones CJ, Kathpalia S, Jackson GG, Mozes M, Maddux MS, Packham D. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir. JAMA. 1985 Dec 27;254(24):3435–3438. [PubMed]
  • Segal R, Shmueli D, Yussim A, Sandbank M, Alteras I, Shapira Z. Renal transplant incidence of superficial fungal infection as related to immunosuppressive therapy. Transplant Proc. 1989 Feb;21(1 Pt 2):2114–2116. [PubMed]
  • Segovia J, Pulpón LA, Crespo MG, Daza R, Rodríguez JC, Rubio A, Serrano S, Carreño MC, Varela A, Arangüena R, et al. Rhodococcus equi: first case in a heart transplant recipient. J Heart Lung Transplant. 1994 Mar-Apr;13(2):332–335. [PubMed]
  • Seltzer J, Broaddus VC, Jacobs R, Golden JA. Reactivation of coccidioides infection. West J Med. 1986 Jul;145(1):96–98. [PMC free article] [PubMed]
  • Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis. 1993 Jan;16(1):54–58. [PubMed]
  • Shaariah W, Morad Z, Suleiman AB. Cryptococcosis in renal transplant recipients. Transplant Proc. 1992 Oct;24(5):1898–1899. [PubMed]
  • Sharples LD, Caine N, Mullins P, Scott JP, Solis E, English TA, Large SR, Schofield PM, Wallwork J. Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease. Transplantation. 1991 Aug;52(2):244–252. [PubMed]
  • Shea BF, Hoffman S, Sesin GP, Hammer SM. Ganciclovir hepatotoxicity. Pharmacotherapy. 1987;7(6):223–226. [PubMed]
  • Shennib H, Massard G, Reynaud M, Noirclerc M. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation. J Heart Lung Transplant. 1994 May-Jun;13(3):514–519. [PubMed]
  • Shrader SK, Watts JC, Dancik JA, Band JD. Disseminated cryptococcosis presenting as cellulitis with necrotizing vasculitis. J Clin Microbiol. 1986 Nov;24(5):860–862. [PMC free article] [PubMed]
  • Shuster EA, Beneke JS, Tegtmeier GE, Pearson GR, Gleaves CA, Wold AD, Smith TF. Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application. Mayo Clin Proc. 1985 Sep;60(9):577–585. [PubMed]
  • Shuttleworth D, Philpot CM, Salaman JR. Cutaneous fungal infection following renal transplantation: a case control study. Br J Dermatol. 1987 Nov;117(5):585–590. [PubMed]
  • Silverman RA, Rhodes AR, Dennehy PH. Disseminated intravascular coagulation and purpura fulminans in a patient with Candida sepsis. Biopsy of purpura fulminans as an aid to diagnosis of systemic Candida infection. Am J Med. 1986 Apr;80(4):679–684. [PubMed]
  • Simmons RL, Matas AJ, Rattazzi LC, Balfour HH, Jr, Howard JR, Najarian JS. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery. 1977 Nov;82(5):537–546. [PubMed]
  • Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Bottenfield S, Conley LJ, Kohlenberg SH, Castro KG, Dahan BA, Schable CA, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med. 1992 Mar 12;326(11):726–732. [PubMed]
  • Simpson GL, Raffin TA, Remington JS. Association of prior nocardiosis and subsequent occurrence of nontuberculous mycobacteriosis in a defined, immunosuppressed population. J Infect Dis. 1982 Aug;146(2):211–219. [PubMed]
  • Sindhuphak W, MacDonald E, Head E, Hudson RD. Exophiala jeanselmei infection in a postrenal transplant patient. J Am Acad Dermatol. 1985 Nov;13(5 Pt 2):877–881. [PubMed]
  • Singer MA, Hagler WS, Grossniklaus HE. Toxoplasma gondii retinochoroiditis after liver transplantation. Retina. 1993;13(1):40–45. [PubMed]
  • Singh N, Dummer JS, Kusne S, Breinig MK, Armstrong JA, Makowka L, Starzl TE, Ho M. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis. 1988 Jul;158(1):124–131. [PMC free article] [PubMed]
  • Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis. 1995 Mar;20(3):617–620. [PubMed]
  • Singh N, Mieles L, Yu VL, Gayowski T. Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B. Clin Infect Dis. 1993 Nov;17(5):906–908. [PubMed]
  • Singh N, Mieles L, Yu VL, Starzl TE. Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? Dig Dis Sci. 1994 Jan;39(1):15–18. [PMC free article] [PubMed]
  • Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med. 1994 Mar 1;120(5):375–381. [PubMed]
  • Sinnott JT, 4th, Emmanuel PJ. Mycobacterial infections in the transplant patient. Semin Respir Infect. 1990 Mar;5(1):65–73. [PubMed]
  • Sinnott JT, 4th, Holt DA. Cryptococcal pyarthrosis complicating gouty arthritis. South Med J. 1989 Dec;82(12):1555–1556. [PubMed]
  • Sklarin NT, Dutcher JP, Wiernik PH. Lymphomas following cardiac transplantation. Case report and review of the literature. Am J Hematol. 1991 Jun;37(2):105–111. [PubMed]
  • Smith EJ, Milligan SL, Filo RS. Salmonella mycotic aneurysm after renal transplantation. South Med J. 1981 Nov;74(11):1399–1401. [PubMed]
  • Smith SD, Jackson RJ, Hannakan CJ, Wadowsky RM, Tzakis AG, Rowe MI. Selective decontamination in pediatric liver transplants. A randomized prospective study. Transplantation. 1993 Jun;55(6):1306–1309. [PubMed]
  • Smith TF, Shelley CD. Detection of IgM antibody to cytomegalovirus and rapid diagnosis of this virus infection by the shell vial assay. J Virol Methods. 1988 Sep;21(1-4):87–96. [PubMed]
  • Smyth RL, Higenbottam TW, Scott JP, Wreghitt TG, Stewart S, Clelland CA, McGoldrick JP, Wallwork J. Herpes simplex virus infection in heart-lung transplant recipients. Transplantation. 1990 Apr;49(4):735–739. [PubMed]
  • Smyth RL, Scott JP, Borysiewicz LK, Sharples LD, Stewart S, Wreghitt TG, Gray JJ, Higenbottam TW, Wallwork J. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Dis. 1991 Dec;164(6):1045–1050. [PubMed]
  • Snydman DR. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S554–S562. [PubMed]
  • Snydman DR, Werner BG, Dougherty NN, Griffith J, Rohrer RH, Freeman R, Jenkins R, Lewis WD, O'Rourke E. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group. Transplant Proc. 1994 Oct;26(5 Suppl 1):23–27. [PubMed]
  • Snydman DR, Werner BG, Dougherty NN, Griffith J, Rubin RH, Dienstag JL, Rohrer RH, Freeman R, Jenkins R, Lewis WD, et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1993 Nov 15;119(10):984–991. [PubMed]
  • Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL, Jr, Levey AS, et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med. 1987 Oct 22;317(17):1049–1054. [PubMed]
  • So S, Mayo C, McCullough C, Jendrisak M, Woodle S, Marsh W, Bailey T. Cytomegalovirus prophylaxis in pediatric renal transplant recipients. Transplant Proc. 1993 Feb;25(1 Pt 2):1414–1415. [PubMed]
  • Solary E, Rifle G, Chalopin JM, Rifle-Mediavilla C, Rebibou JM, Camerlynck P, Justrabo E, Cuisenier B, Caillot D, Mousson C, et al. Disseminated aspergillosis revealed by thyroiditis in a renal allograft recipient. Transplantation. 1987 Dec;44(6):839–840. [PubMed]
  • Specht EE. Candida pyarthrosis of the hip and renal homotransplant. Report of a case treated by femoral head and neck resection and 5-fluorocytosine. Clin Orthop Relat Res. 1977 Jul-Aug;(126):176–177. [PubMed]
  • Spector SA, Merrill R, Wolf D, Dankner WM. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol. 1992 Sep;30(9):2359–2365. [PMC free article] [PubMed]
  • Spence RK, Dafoe DC, Rabin G, Grossman RA, Naji A, Barker CF, Perloff LJ. Mycobacterial infections in renal allograft recipients. Arch Surg. 1983 Mar;118(3):356–359. [PubMed]
  • Spencer GD, Hackman RC, McDonald GB, Amos DE, Cunningham BA, Meyers JD, Thomas ED. A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation. 1986 Dec;42(6):602–607. [PubMed]
  • Spieker C, Barenbrock M, Tepel M, Buchholz B, Rahn KH, Zidek W. Pentamidine inhalation as a prophylaxis against Pneumocystis carinii pneumonia after therapy of acute renal allograft rejection with orthoclone (OKT3). Transplant Proc. 1992 Dec;24(6):2602–2603. [PubMed]
  • Sridhar NR, Tchervenkov JI, Weiss MA, Hijazi YM, First MR. Disseminated histoplasmosis in a renal transplant patient: a cause of renal failure several years following transplantation. Am J Kidney Dis. 1991 Jun;17(6):719–721. [PubMed]
  • Stamm AM, Dismukes WE, Simmons BP, Cobbs CG, Elliott A, Budrich P, Harmon J. Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases. Rev Infect Dis. 1982 May-Jun;4(3):665–682. [PubMed]
  • Stamm AM, Smith SH, Kirklin JK, McGiffin DC. Listerial myocarditis in cardiac transplantation. Rev Infect Dis. 1990 Sep-Oct;12(5):820–823. [PubMed]
  • Starzl T, Porter KA, Schroter G, Corman J, Groth CG, Sharp HL. Autopsy findings in a long-surviving liver recipient. N Engl J Med. 1973 Jul 12;289(2):82–84. [PMC free article] [PubMed]
  • Starzl TE, Koep L, Porter KA, Schroter GP, Weil R, 3rd, Hartley RB, Halgrimson CG. Decline in survival after liver transplantation. Arch Surg. 1980 Jul;115(7):815–819. [PMC free article] [PubMed]
  • Steffen R, Reinhartz O, Blumhardt G, Bechstein WO, Raakow R, Langrehr JM, Rossaint R, Slama K, Neuhaus P. Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantations. Transpl Int. 1994;7(2):101–108. [PubMed]
  • Stein DS, Verano AS, Levandowski RA. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation. Am J Gastroenterol. 1988 Jun;83(6):684–686. [PubMed]
  • Steinhoff G, Behrend M, Wagner TO, Höper MH, Haverich A. Early diagnosis and effective treatment of pulmonary CMV infection after lung transplantation. J Heart Lung Transplant. 1991 Jan-Feb;10(1 Pt 1):9–14. [PubMed]
  • Steinmuller DR, Graneto D, Swift C, Novick AC, Streem SB, Cunningham RJ, Hodge E, Bretan P. Use of intravenous immunoglobulin prophylaxis for primary cytomegalovirus infection post living-related-donor renal transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):2069–2071. [PubMed]
  • Steinmuller DR, Novick AC, Streem SB, Graneto D, Swift C. Intravenous immunoglobulin infusions for the prophylaxis of secondary cytomegalovirus infection. Transplantation. 1990 Jan;49(1):68–70. [PubMed]
  • Stinson EB, Bieber CP, Griepp RB, Clark DA, Shumway NE, Remington JS. Infectious complications after cardiac transplantation in man. Ann Intern Med. 1971 Jan;74(1):22–36. [PubMed]
  • Stolf NA, Higushi L, Bocchi E, Bellotti G, Auler JO, Uip D, Amato Neto V, Pileggi F, Jatene AD. Heart transplantation in patients with Chagas' disease cardiomyopathy. J Heart Transplant. 1987 Sep-Oct;6(5):307–312. [PubMed]
  • Stoutenbeek CP, Van Saene HK, Miranda DR, Zandstra DF. A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract. Acta Anaesthesiol Belg. 1983 Sep;34(3):209–221. [PubMed]
  • Stratta R, Shaefer M, Markin R, Bradshaw K, Donovan J, Wood R, Langnas A, Reed E, Woods G, Zetterman R, et al. Ganciclovir therapy for viral disease in liver transplant recipients. Transplant Proc. 1991 Jun;23(3):1968–1968. [PubMed]
  • Stratta RJ. Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation. Transplant Proc. 1993 Oct;25(5 Suppl 4):15–21. [PubMed]
  • Stratta RJ, Shaefer MS, Markin RS, Wood RP, Kennedy EM, Langnas AN, Reed EC, Woods GL, Donovan JP, Pillen TJ, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg. 1989 Dec;124(12):1443–1450. [PubMed]
  • Stratta RJ, Shaeffer MS, Markin RS, Wood RP, Langnas AN, Reed EC, Donovan JP, Woods GL, Bradshaw KA, Pillen TJ, et al. Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci. 1992 May;37(5):673–688. [PubMed]
  • Stratta RJ, Shaefer MS, Cushing KA, Markin RS, Reed EC, Langnas AN, Pillen TJ, Shaw BW., Jr A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. Arch Surg. 1992 Jan;127(1):55–64. [PubMed]
  • Stratta RJ, Shaefer MS, Cushing KA, Markin RS, Wood RP, Langnas AN, Reed EC, Woods GL, Donovan JP, Pillen TJ, et al. Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients. Transplantation. 1991 Jan;51(1):90–97. [PubMed]
  • Stratta RJ, Taylor RJ, Bynon JS, Lowell JA, Cattral MS, Frisbie K, Miller S, Radio SJ, Brennan DC. Viral prophylaxis in combined pancreas-kidney transplant recipients. Transplantation. 1994 Feb 27;57(4):506–512. [PubMed]
  • Stratta RJ, Wood RP, Langnas AN, Duckworth RM, Shaefer MS, Marujo W, Pillen TJ, Markin RS, Shaw BW., Jr Donor selection for orthotopic liver transplantation: lack of an effect of gender or cytomegalovirus (CMV) status. Transplant Proc. 1990 Apr;22(2):410–413. [PubMed]
  • Studemeister AE, Kozak K, Garrity E, Venezio FR. Survival of a heart transplant recipient after pulmonary cavitary mucormycosis. J Heart Transplant. 1988 Mar-Apr;7(2):159–161. [PubMed]
  • Sudduth EJ, Crumbley AJ, 3rd, Farrar WE. Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans. Clin Infect Dis. 1992 Oct;15(4):639–644. [PubMed]
  • Sugar AM, Restrepo A, Stevens DA. Paracoccidioidomycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis. 1984 Feb;129(2):340–342. [PubMed]
  • Sughayer M, DeGirolami PC, Khettry U, Korzeniowski D, Grumney A, Pasarell L, McGinnis MR. Human infection caused by Exophiala pisciphila: case report and review. Rev Infect Dis. 1991 May-Jun;13(3):379–382. [PubMed]
  • Sumrani N, Delaney V, Hong JH, Sommer BG. Mycobacterial avium-intracellulare infection of a renal allograft. Clin Nephrol. 1991 Jan;35(1):45–46. [PubMed]
  • Sundberg R, Shapiro R, Darras F, Jensen C, Scantlebury V, Jordan M, McCauley J, Kusne S, Edmond MB, Ho M, et al. A tuberculosis outbreak in a renal transplant program. Transplant Proc. 1991 Dec;23(6):3091–3092. [PMC free article] [PubMed]
  • Sutherland DE, Chan FY, Fourcar E, Simmons PL, Howard RJ, Najarian JS. The bleeding cecal ulcer in transplant patients. Surgery. 1979 Sep;86(3):386–398. [PubMed]
  • Suzuki T, Takano Y, Yamashita K, Sato K, Kakita A, Okudaira M. A possible role for Epstein-Barr virus in tumorigenesis after immunosuppression in cases of renal transplantation. J Cancer Res Clin Oncol. 1993;119(10):627–629. [PubMed]
  • Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fisher RI. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med. 1990 Dec 20;323(25):1723–1728. [PubMed]
  • Talseth T, Holdaas H, Albrechtsen D, Berg KJ, Fauchald P, Naalsund A, Nordal KP, Skar AG, Sødal G, Flatmark A. Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients. Transplant Proc. 1988 Jun;20(3):400–401. [PubMed]
  • Tang CM, Cohen J, Rees AJ, Holden DW. Molecular epidemiological study of invasive pulmonary aspergillosis in a renal transplantation unit. Eur J Clin Microbiol Infect Dis. 1994 Apr;13(4):318–321. [PubMed]
  • Telenti A, Smith TF, Ludwig J, Keating MR, Krom RA, Wiesner RH. Epstein-Barr virus and persistent graft dysfunction after liver transplantation. Hepatology. 1991 Aug;14(2):282–286. [PubMed]
  • Tenschert W, Gonnermann D, Meyer-Moldenhauer WH, Cremaschi L, Huland H. Management of cytomegalovirus infection in high-risk recipients after renal transplantation: prophylaxis by hyperimmunoglobulins or DHPG treatment? Transplant Proc. 1993 Dec;25(6):3256–3258. [PubMed]
  • Terrault NA, Wright TL, Pereira BJ. Hepatitis C infection in the transplant recipient. Infect Dis Clin North Am. 1995 Dec;9(4):943–964. [PubMed]
  • Thaler F, Gotainer B, Teodori G, Dubois C, Loirat P. Mediastinitis due to Nocardia asteroides after cardiac transplantation. Intensive Care Med. 1992;18(2):127–128. [PubMed]
  • Thomalla JV, Steidle CP, Leapman SB, Filo RS. Ureteral obstruction of a renal allograft secondary to Candida krusei. Transplant Proc. 1988 Jun;20(3):551–554. [PubMed]
  • Thomas DW, Ramsahoye B, Jasani B, Lim SH. Epstein-Barr virus in squamous cell carcinoma after renal transplantation. Transplantation. 1995 Aug 27;60(4):390–392. [PubMed]
  • Thomas PA, Jr, Mozes MF, Jonasson O. Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recipients. Arch Surg. 1979 May;114(5):597–599. [PubMed]
  • Thorsteinsson SB, Musher DM, Ortiz LR, Wolfe KS, Weinman EJ, Schloeder FX. Phycomycosis in a renal transplant recipient. Tex Med. 1976 Apr;72(4):71–75. [PubMed]
  • Tice AD, Solomon RJ. Disseminated Mycobacterium chelonei infection: response to sulfonamides. Am Rev Respir Dis. 1979 Jul;120(1):197–201. [PubMed]
  • Tinelli M, Percivalle E, Zambelli A, Grossi P, Maccabruni A. Cytomegalovirus prophylaxis by intravenous immunoglobulins in five heart transplanted patients. Boll Ist Sieroter Milan. 1990 Jun;69(2):459–467. [PubMed]
  • Tokunaga Y, Concepcion W, Berquist WE, Cox KL, Wiviott LD, Garcia-Kennedy R, Itasaka H, Nakazato P, Esquivel CO. Graft involvement by Legionella in a liver transplant recipient. Arch Surg. 1992 Apr;127(4):475–477. [PubMed]
  • Tolkoff-Rubin NE, Conti DJ, Doran M, DelVecchio A, Rubin RH. Fluconazole in the treatment of invasive candidal and cryptococcal infections in organ transplant recipients. Pharmacotherapy. 1990;10(6 ):159S–163S. [PubMed]
  • Tolkoff-Rubin NE, Cosimi AB, Russell PS, Rubin RH. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis. 1982 Mar-Apr;4(2):614–618. [PubMed]
  • Tollemar J, Ericzon BG, Holmberg K, Andersson J. The incidence and diagnosis of invasive fungal infections in liver transplant recipients. Transplant Proc. 1990 Feb;22(1):242–244. [PubMed]
  • Tollemar J, Ericzon BG, Barkholt L, Andersson J, Ringdén O, Groth CG. Risk factors for deep candida infections in liver transplant recipients. Transplant Proc. 1990 Aug;22(4):1826–1827. [PubMed]
  • Tollemar J, Höckerstedt K, Ericzon BG, Jalanko H, Ringdén O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation. 1995 Jan 15;59(1):45–50. [PubMed]
  • Tomlanovich SJ, Sabatte-Caspillo J, Melzer J, Amend W, Vincenti F, Feduska N, Salvatierra O. The incidence and impact of herpes simplex virus infections in the first month following renal transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):2091–2092. [PubMed]
  • Torre-Cisneros J, Lopez OL, Kusne S, Martinez AJ, Starzl TE, Simmons RL, Martin M. CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):188–193. [PMC free article] [PubMed]
  • Torre-Cisneros J, Mañez R, Kusne S, Alessiani M, Martin M, Starzl TE. The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc. 1991 Dec;23(6):3040–3041. [PMC free article] [PubMed]
  • Trulock EP, Bolman RM, Genton R. Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis. Am Rev Respir Dis. 1989 Sep;140(3):802–805. [PubMed]
  • Tsanaclis AM, de Morais CF. Cerebral toxoplasmosis after renal transplantation. Case report. Pathol Res Pract. 1986 Jun;181(3):339–343. [PubMed]
  • Tuder RM, Renya GS, Bensch K. Mycobacterial coronary arteritis in a heart transplant recipient. Hum Pathol. 1986 Oct;17(10):1072–1074. [PubMed]
  • Valantine HA, Hunt SA, Gibbons R, Billingham ME, Stinson EB, Popp RL. Increasing pericardial effusion in cardiac transplant recipients. Circulation. 1989 Mar;79(3):603–609. [PubMed]
  • van den Berg AP, Klompmaker IJ, Haagsma EB, Scholten-Sampson A, Bijleveld CM, Schirm J, van der Giessen M, Slooff MJ, The TH. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis. 1991 Aug;164(2):265–270. [PubMed]
  • van den Berg AP, van Son WJ, Haagsma EB, Klompmaker IJ, Tegzess AM, Schirm J, Dijkstra G, van der Giessen M, Slooff MJ, The TH. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. Transplantation. 1993 Apr;55(4):847–851. [PubMed]
  • van den Elshout FJ, Huysmans FT, Muytjens HL, Koene RA. Cryptococcus neoformans meningitis following renal transplantation. Neth J Med. 1987 Oct;31(3-4):183–190. [PubMed]
  • van der Bij W, Schirm J, Torensma R, van Son WJ, Tegzess AM, The TH. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol. 1988 Dec;26(12):2531–2535. [PMC free article] [PubMed]
  • van der Vliet JA, Tidow G, Kootstra G, van Saene HF, Krom RA, Sloof MJ, Weening JJ, Tegzess AM, Meijer S, van Boven WP. Transplantation of contaminated organs. Br J Surg. 1980 Aug;67(8):596–598. [PubMed]
  • van der Waaij D. Colonization resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother. 1982 Oct;10(4):263–270. [PubMed]
  • Van Etta LL, Peterson LR, Gerding DN. Acremonium falciforme (Cephalosporium falciforme) mycetoma in a renal transplant patient. Arch Dermatol. 1983 Aug;119(8):707–708. [PubMed]
  • van Gelder T, Kroes LC, Mulder A, Gratama JW, Weimar W. A living-related kidney donor as the source of a nearly fatal primary Epstein-Barr virus infection following transplantation. Transplantation. 1994 Oct 15;58(7):852–855. [PubMed]
  • van Son WJ, van den Berg AP, The TH, Tegzess AM. Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation. Transplant Proc. 1993 Feb;25(1 Pt 2):1436–1438. [PubMed]
  • Van Thiel DH, Gavaler JS, Schade RR, Chien MC, Starzl TE. Cytomegalovirus infection and gastric emptying. Transplantation. 1992 Jul;54(1):70–73. [PMC free article] [PubMed]
  • Vartivarian SE, Coudron PE, Markowitz SM. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med. 1987 Nov;83(5):949–952. [PubMed]
  • Vasquez EM, Sanchez J, Pollak R, Vrahnos D, Fabrega AJ, Maddux MS. High-dose oral acyclovir prophylaxis for primary cytomegalovirus infection in seronegative renal allograft recipients. Transplantation. 1993 Feb;55(2):448–450. [PubMed]
  • Venizelos PC, Lopata M, Bardawil WA, Sharp JT. Respiratory failure due to Strongyloides stercoralis in a patient with a renal transplant. Chest. 1980 Jul;78(1):104–106. [PubMed]
  • Versluis DJ, Beyer WE, Masurel N, Wenting GJ, Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation. 1986 Oct;42(4):376–379. [PubMed]
  • Viviani MA, Tortorano AM, Langer M, Almaviva M, Negri C, Cristina S, Scoccia S, De Maria R, Fiocchi R, Ferrazzi P, et al. Experience with itraconazole in cryptococcosis and aspergillosis. J Infect. 1989 Mar;18(2):151–165. [PubMed]
  • Wackym PA, Gray GF, Jr, Richie RE, Gregg CR. Cutaneous chromomycosis in renal transplant recipients. Successful management in two cases. Arch Intern Med. 1985 Jun;145(6):1036–1037. [PubMed]
  • Wade JC, Hintz M, McGuffin R, Springmeyer SC, Connor JD, Meyers JD. Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med. 1982 Jul 20;73(1A):249–256. [PubMed]
  • Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology. 1995 May;21(5):1328–1336. [PubMed]
  • Wagner D, Wagenbreth I, Stachan-Kunstyr R, Flik J. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients. Clin Investig. 1992 Jul;70(7):585–587. [PubMed]
  • Wagner FM, Reichenspurner H, Uberfuhr P, Weiss M, Fingerle V, Reichart B. Toxoplasmosis after heart transplantation: diagnosis by endomyocardial biopsy. J Heart Lung Transplant. 1994 Sep-Oct;13(5):916–918. [PubMed]
  • Wajszczuk CP, Dummer JS, Ho M, Van Thiel DH, Starzl TE, Iwatsuki S, Shaw B., Jr Fungal infections in liver transplant recipients. Transplantation. 1985 Oct;40(4):347–353. [PMC free article] [PubMed]
  • Walder BK, Jeremy D, Charlesworth JA, Macdonald GJ, Pussell BA, Robertson MR. The skin and immunosuppression. Australas J Dermatol. 1976 Dec;17(3):94–97. [PubMed]
  • Walker DH, Adamec T, Krigman M. Disseminated petriellidosis (allescheriosis). Arch Pathol Lab Med. 1978 Mar;102(3):158–160. [PubMed]
  • Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, McGregor CG, Paya CV. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis. 1995 May;20(5):1346–1353. [PubMed]
  • Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CG. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant. 1995 Mar-Apr;14(2):214–221. [PubMed]
  • Walker SD, Clark RV, King CT, Humphries JE, Lytle LS, Butkus DE. Fatal disseminated Conidiobolus coronatus infection in a renal transplant patient. Am J Clin Pathol. 1992 Dec;98(6):559–564. [PubMed]
  • Wallace RJ, Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis. 1992 Aug;166(2):405–412. [PubMed]
  • Wallace RJ, Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med. 1993 Sep 15;119(6):482–486. [PubMed]
  • Walzer Y, Bear RA. Ureteral obstruction of renal transplant due to ureteral candidiasis. Urology. 1983 Mar;21(3):295–297. [PubMed]
  • Waser M, Maggiorini M, Lüthy A, Laske A, von Segesser L, Mohacsi P, Opravil M, Turina M, Follath F, Gallino A. Infectious complications in 100 consecutive heart transplant recipients. Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):12–18. [PubMed]
  • Watanabe M, Hotchi M, Nagasaki M. An autopsy case of disseminated histoplasmosis probably due to infection from a renal allograft. Acta Pathol Jpn. 1988 Jun;38(6):769–780. [PubMed]
  • Watson AJ, Russell RP, Cabreja RF, Braverman R, Whelton A. Cure of cryptococcal infection during continued immunosuppressive therapy. Q J Med. 1985 May;55(217):169–172. [PubMed]
  • Watson AJ, Whelton A, Russell RP. Cure of cryptococcemia and preservation of graft function in a renal transplant recipient. Arch Intern Med. 1984 Sep;144(9):1877–1878. [PubMed]
  • Watson FS, O'Connell JB, Amber IJ, Renlund DG, Classen D, Johnston JM, Smith CB, Bristow MR. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG). J Heart Transplant. 1988 Mar-Apr;7(2):102–105. [PubMed]
  • Weber J, Mettang T, Staerz E, Machleidt C, Kuhlmann U. Pulmonary disease due to Mycobacterium xenopi in a renal allograft recipient: report of a case and review. Rev Infect Dis. 1989 Nov-Dec;11(6):964–969. [PubMed]
  • Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS. Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg. 1983 Nov;198(5):622–629. [PubMed]
  • Weimar W, Kramer P, Bijnen AB, Jeekel J, Rothbarth PH, Masurel N. The incidence of cytomegalo- and herpes simplex virus infections in renal allograft recipients treated with high dose recombinant leucocyte interferon: a controlled study. Scand J Urol Nephrol Suppl. 1985;92:37–39. [PubMed]
  • Weimar W, Lameijer LD, Edy VG, Schellekens H. Prophylactic use of interferon in renal allograft recipients. Transplant Proc. 1979 Mar;11(1):69–70. [PubMed]
  • Weimar W, Metselaar HJ, Balk AH, Mochtar B, Rothbarth PH, Jeekel J. Passive immunization to prevent cytomegalovirus disease after kidney and heart transplantation. Transplant Proc. 1990 Feb;22(1):229–232. [PubMed]
  • Weiss JN, Hutchins RK, Balogh K. Simultaneous aspergillus endophthalmitis and cytomegalovirus retinitis after kidney transplantation. Retina. 1988;8(3):193–198. [PubMed]
  • Weller IV, Copland P, Gabriel R. Strongyloides stercoralis infection in renal transplant recipients. Br Med J (Clin Res Ed) 1981 Feb 14;282(6263):524–524. [PMC free article] [PubMed]
  • Welty FK, McLeod GX, Ezratty C, Healy RW, Karchmer AW. Pseudallescheria boydii endocarditis of the pulmonic valve in a liver transplant recipient. Clin Infect Dis. 1992 Nov;15(5):858–860. [PubMed]
  • Werner BG, Snydman DR, Freeman R, Rohrer R, Tilney NL, Kirkman RL. Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group. Transplant Proc. 1993 Feb;25(1 Pt 2):1441–1443. [PubMed]
  • Weston MW. Invasive pulmonary aspergillosis in the early postcardiac transplantation period. Clin Cardiol. 1990 Jun;13(6):443–446. [PubMed]
  • Wheat LJ, Smith EJ, Sathapatayavongs B, Batteiger B, Filo RS, Leapman SB, French MV. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Intern Med. 1983 Apr;143(4):703–707. [PubMed]
  • Wheeler JS, Jr, Culkin DJ, O'Connell J, Winters G. Nocardia epididymo-orchitis in an immunosuppressed patient. J Urol. 1986 Dec;136(6):1314–1315. [PubMed]
  • White FV, Reyes J, Jaffe R, Yunis EJ. Pathology of intestinal transplantation in children. Am J Surg Pathol. 1995 Jun;19(6):687–698. [PubMed]
  • White JV, Garvey G, Hardy MA. Fatal strongyloidiasis after renal transplantation: a complication of immunosuppression. Am Surg. 1982 Jan;48(1):39–41. [PubMed]
  • Wiesner RH. The incidence of gram-negative bacterial and fungal infections in liver transplant patients treated with selective decontamination. Infection. 1990;18 (Suppl 1):S19–S21. [PubMed]
  • Wiesner RH. Selective bowel decontamination for infection prophylaxis in liver transplantation patients. Transplant Proc. 1991 Jun;23(3):1927–1928. [PubMed]
  • Wiesner RH, Hermans P, Rakela J, Perkins J, Washington J, DiCecco S, Krom RA. Selective bowel decontamination to prevent gram-negative bacterial and fungal infection following orthotopic liver transplantation. Transplant Proc. 1987 Feb;19(1 Pt 3):2420–2423. [PubMed]
  • Wiesner RH, Hermans PE, Rakela J, Washington JA, 2nd, Perkins JD, DiCecco S, Krom R. Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation. 1988 Mar;45(3):570–574. [PubMed]
  • Wilczek H, Kallings I, Nyström B, Hoffner S. Nosocomial Legionnaires' disease following renal transplantation. Transplantation. 1987 Jun;43(6):847–851. [PubMed]
  • Wiles HB, Laver J, Baum D. T-cell lymphoma in a child after heart transplantation. J Heart Lung Transplant. 1994 Nov-Dec;13(6):1019–1023. [PubMed]
  • Wilson CB, Siber GR, O'Brien TF, Morgan AP. Phycomycotic gangrenous cellulitis. A report of two cases and a review of the literature. Arch Surg. 1976 May;111(5):532–538. [PubMed]
  • Wilson JP, Turner HR, Kirchner KA, Chapman SW. Nocardial infections in renal transplant recipients. Medicine (Baltimore) 1989 Jan;68(1):38–57. [PubMed]
  • Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis. 1995 Nov;21(5):1077–1091. [PubMed]
  • Winston DJ, Ho WG, Bartoni K, Holland GN, Mitsuyasu RT, Gale RP, Busuttil RW, Champlin RE. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S547–S553. [PubMed]
  • Winston DJ, Wirin D, Shaked A, Busuttil RW. Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet. 1995 Jul 8;346(8967):69–74. [PubMed]
  • Wise KA, Speed BR, Ellis DH, Andrew JH. Two fatal infections in immunocompromised patients caused by Scedosporium inflatum. Pathology. 1993 Apr;25(2):187–189. [PubMed]
  • Wolfson JS, Sober AJ, Rubin RH. Dermatologic manifestations of infections in immunocompromised patients. Medicine (Baltimore) 1985 Mar;64(2):115–133. [PubMed]
  • Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis. 1992 Jul;15(1):1–10. [PubMed]
  • Wong SY, Allen DM. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: case report. Clin Infect Dis. 1992 Jan;14(1):232–234. [PubMed]
  • Wong T, Lavaud S, Toupance O, Carquin J, Wynckel A, Melin JP, Hanrotel C, Chanard J. Failure of acyclovir to prevent cytomegalovirus infection in renal allograft recipients. Transpl Int. 1993;6(5):285–289. [PubMed]
  • Wood GM, McCormack JG, Muir DB, Ellis DH, Ridley MF, Pritchard R, Harrison M. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis. 1992 May;14(5):1027–1033. [PubMed]
  • Woods GL, Washington JA., 2nd Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis. 1987 Mar-Apr;9(2):275–294. [PubMed]
  • Wreghitt TG, Gray JJ, Pavel P, Balfour A, Fabbri A, Sharples LD, Wallwork J. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int. 1992 Sep;5(4):197–200. [PubMed]
  • Wreghitt TG, Hakim M, Gray JJ, Balfour AH, Stovin PG, Stewart S, Scott J, English TA, Wallwork J. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol. 1989 Feb;42(2):194–199. [PMC free article] [PubMed]
  • Wreghitt TG, Whipp PJ, Bagnall J. Transmission of chickenpox to two intensive care unit nurses from a liver transplant patient with zoster. J Hosp Infect. 1992 Feb;20(2):125–126. [PubMed]
  • Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, Wilber J, Sheridan P, Urdea M. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology. 1994 Oct;20(4 Pt 1):773–779. [PubMed]
  • Wright TL. Cytomegalovirus infection and vanishing bile duct syndrome: culprit or innocent bystander? Hepatology. 1992 Aug;16(2):494–496. [PubMed]
  • Wyner LM. The evaluation and management of urinary tract infections in recipients of solid-organ transplants. Semin Urol. 1994 May;12(2):134–139. [PubMed]
  • Yalcin S, Karpuzoglu T, Suleymanlar G, Mutlu G, Mukai T, Yamamoto T, Isegawa Y, Yamanishi K. Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey. Arch Virol. 1994;136(1-2):183–190. [PubMed]
  • Yoshino MT, Hillman BJ, Galgiani JN. Coccidioidomycosis in renal dialysis and transplant patients: radiologic findings in 30 patients. AJR Am J Roentgenol. 1987 Nov;149(5):989–992. [PubMed]
  • Young CN, Meyers AM. Opportunistic fungal infection by Fusarium oxysporum in a renal transplant patient. Sabouraudia. 1979 Sep;17(3):219–223. [PubMed]
  • Zainudin BM, Kassim F, Annuar NM, Lim CS, Ghazali AK, Murad Z. Disseminated histoplasmosis presenting with ileal perforation in a renal transplant recipient. J Trop Med Hyg. 1992 Aug;95(4):276–279. [PubMed]
  • Zamora I, Simon JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol. 1994 Apr;8(2):190–192. [PubMed]
  • Zamora MR, Fullerton DA, Campbell DN, Leone S, Diercks MJ, Fisher JH, Badesch DB, Grover FL. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. Transplant Proc. 1994 Oct;26(5 Suppl 1):49–51. [PubMed]
  • Zeluff BJ. Fungal pneumonia in transplant recipients. Semin Respir Infect. 1990 Mar;5(1):80–89. [PubMed]
  • Zitelli BJ, Gartner JC, Malatack JJ, Urbach AH, Miller JW, Williams L, Kirkpatrick B, Breinig MK, Ho M. Pediatric liver transplantation: patient evaluation and selection, infectious complications, and life-style after transplantation. Transplant Proc. 1987 Aug;19(4):3309–3316. [PubMed]
  • Zucker K, Cirocco R, Roth D, Burke G, Nery J, Esquenazi V, Miller J. Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation. Transplant Proc. 1995 Feb;27(1):943–944. [PubMed]
  • Zwas ST, Czerniak P. Head and brain scan findings in rhinocerebral mucormycosis: case report. J Nucl Med. 1975 Oct;16(10):925–927. [PubMed]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)